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ABSTRACT OF THE DISSERTATION 
 APPLICATIONS OF PAPER MICROFLUIDIC SYSTEMS  
IN THE FIELD DETECTION OF DRUGS OF ABUSE 
by 
Ling Wang 
Florida International University, 2017 
Miami, Florida 
Professor Bruce McCord, Major Professor 
Over the years, colorimetric reagents and immunology have been widely used in 
screening tests for illicit drugs; however, the test kits are not always convenient 
for field use and often require the user to mix and develop a specific set of 
reagents. In our project, we have been working on alternative platforms based on 
paper microfluidic devices (uPADs) for field testing.   These devices utilize wax 
channels printed on paper to direct the analyte towards a specific set of chemical 
reagents.  Using the procedure, we have developed a six-channel chip that 
adapts known colorimetric reagents targeting cocaine, opiates, amphetamines 
and ketamine for multiplex detection.   For more sensitive and specific 
determinations than the colorimetric reagents, we have also developed a paper 
device that utilizes the interaction between gold nanoparticles and drug specific 
aptamers. 
The µPADs using colorimetric reagent are designed as a six-channel multiplexed 
system.  Sequences of different reagents applied to each channel to produce a 
series of reactions and the color changes appear at the end of each 
  vi 
channel.  The entire process takes less than five minutes.  The adjusted reagents 
produce specific color changes for seized drugs on the paper microfluidic 
devices.  Procedures have been developed for the detection of cocaine, 
ketamine, codeine, ephedrine, morphine, amphetamine, methamphetamine, and 
MDMA.  These devices have been tested for sensitivity, specificity and stability 
against a variety of potential interferences and test conditions.  
Gold nanoparticles (AuNPs)/ aptamers µPADs were developed to detect cocaine.  
The presence of cocaine cause the binding with aptamers, and the gold 
nanoparitcles produced a salt-indicated aggregations and gave a color change of 
AuNPs from red to black.  The absence of cocaine allowed the aptamers freely to 
bind gold nanoparticles, and no color change occured.  The device had a 
preliminary validation of sensitvity and specificity against a variety of potential 
interferences.   
The use of paper microfluidic devices permits the development of rapid, 
inexpensive and easily operated tests for drug samples in the field.  They present 
a safe and convenient presumptive tool that can be used in the field.  
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Chapter 1. Short History of Drugs of Abuse and Analysis 
1. Introduction 
Drug abuse has been a global problem for many years.  The World Drug 
Report has estimated that up to 250 million people used illicit drugs in 
2010. [1]  In 2014, the report estimated that one in 20 adult individuals 
were drug users ,and over 29 million drug abusers suffered disorders such 
as HIV and hepatitis; however, only 4.83 million drug addicts with these 
issues were in treatment. [2]  Drug users have higher risks of health 
problems than other non-drug users [3], and are often involved in 
antisocial behavior.  Almost one in five sentenced prisoners are involved in 
a drug-related offense, and the estimated global drug-related deaths was 
207,400 per year. [4]  In the United States, abuse of illicit and prescription 
drugs cost millions of dollars in crime, health and productivity. [5]     
The term ‘drug of abuse’ does not have the  same meaning as the term 
‘illicit drug’ despite the fact they are often mixed in daily life. [6]    For 
example, alcohol and tobacco are commonly abused drugs but are legal. 
[6]  Patterns of drug abuse change with the time and country.  Even in the 
same country, there exists  a diversity of drug consumption depending on 
the period, local government and financial status. [4, 6]  For example, in 
Southeast Asia there is a  higher consumption of ketamine than in 
northern Europe [7], while North America and Western Europe have a 
greater consumption of cannabis than other regions.   In South America, 
increasing abuse of cocaine has become a great problem. [4]   
  2 
Drug control programs have been established for many years.  Since the 
1980s, the U.S. government has yearly spent billions of dollars in an 
attempt to control the illicit drug market; however, the results are limited. 
[8]  There is a continuing development of new drug analogs along with an 
increasing use of mixtures of synthetic and traditional drugs.  The 
increasing availability of dangerous drugs creates problems in legislation, 
control, interdiction, and forensic analysis. 
 
a. Overview of SAMHSA 5 
There are an overwhelming number of drugs of abuse, therefore in our 
research project, we have focused on a list of important compounds 
promulgated by the National Institute on Drug Abuse (SAMHSA-5).  The 
SAMHSA-5 does not cover the entire set of drugs of abuse, such as new 
“designer drugs”, legitimate drugs, or other less prevalent illicit drugs. [9]  
The primary concern is to control amphetamines (amphetamine and 
methamphetamine), cocaine, marijuana, opiates (codeine, morphine, 
heroin) and phencyclidine (PCP).  These compounds are commonly 
detected as part of a standard five-drug panel.  
 
(1) Cocaine  
Cocaine (methylbenzoylecgonine) is an alkaloid which consists an ester of 
benzoic acid combined with an amino alcohol methylecgonine.  Cocaine 
hydrochloride is a white crystalline salt and it can precipitate to yield 
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cocaine free base when mixed with potassium permanganate and 
aqueous ammonia. [9] Cocaine can be prepared as either the purified 
product from the coca paste or a synthesized product from ecgonine via 
the Mannich reaction. [9,10]  
Cocaine has been used as a topical local anesthetic in medicine.  Its mode 
of action is to block sodium channels in the central nervous system and 
increase the threshold required to generate an action potential. [10]   
Acute abuse of cocaine can cause cocaine intoxication, in which 
excessive stimulation occurs in the central nervous system. Chironic 
usage can cause psychological dependence.   
The routes of administration of cocaine are via intravenous (IV), intranasal 
(IN), oral (PO) or smoking (SM).  Comparing the drug bioavailability, the 
oral route has the lowest bioavailability (20%), the IN route is dose 
dependent with an estimated range of 25-94%, the SM route has a range 
of 57-70%, and the IV route has 100% drug bioavailability. [10] Cocaine 
and its metabolites can stay in urine or blood for up to 10 days. [9,10] The 
primary metabolites of cocaine are benzoylecgonine and ecogonine 
methyl ester.  Cutoff concentrations of cocaine and its metabolites are 
150ng/mL in screening tests and 100 ng/mL in confirmatory tests. [11] 
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Figure 1.1. Main pathways in the primary metabolism of cocaine. 
 
(2) Amphetamines  
Amphetamines are central nervous system (CNS) stimulants that mimic 
natural hormones.  Amphetamine and methamphetamine belong to the 
phenethylamine group, and are classified as Schedule II controlled 
substances. [9,10] Amphetamines can increase dopamine concentration 
at nerve endings and stimulate the CNS.  Methamphetamine has a better 
CNS efficacy than amphetamine because the extra methyl group 
increases its lipophilicity and entry into the CNS. (Figure 1.2) In the urine 
samples, up to 45% of methamphetamine and 4-7% of amphetamine are 
excreted as the unchanged parent drugs in a 24-hour period. [9] For 
detection, the analytical cutoff is 500 ng/mL in screening tests and 250 
ng/mL in confirmation tests. [11]  
N
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Figure 1.2. Structures of commonly abused phenethyl amines: 
methamphetamine, amphetamine, and 3,4-methylenedioxyamphetamine 
(MDMA). 
 
3,4-methylenedioxyamphetamine (MDMA) is a designer drug of the 
phenethylamine class.  It was previously used in therapeutic treatment, 
however today it is classed as a Schedule I controlled substance with no 
approved medical use.  MDMA has a similar sympathomimtic activity to 
amphetamine, but its overdose can affect multiple organ systems. [10] 
MDMA has a cutoff level of 500 ng/mL in screening tests and 250 ng/mL in 
confirmation tests. [11]  
 
(3) Phencyclidines  
Phencyclidines(PCPs) are hallucinogens which interact with 
neurotransmitter systems and dopaminergic systems.  Ketamine is an 
analog of PCP and its chemical structure is shown in Figure 1.3.  Its salt 
form is ketamine hydrochloride and this form is used in medicines.  
Ketamine is structurally and pharmacologically related to PCP.  It is 
H2
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classified as a Schedule III controlled substance because it can be used 
as a drug for sexual assault because of its hallucinogenic properties.  
Phencyclidine has a cutoff of 25 ng/mL in screening tests and 25 ng/mL in 
confirmation tests. [11] 
 
Figure 1.3. Structure of PCP and Ketamine.  
  
(4) Cannabinoids  
Cannabinoids are psychoactive products extracted from the Cannabis 
sativa plant complex.  The products can come from whole plants or finely 
chopped leaves and buds. D9-Tetrahydrocannabinol (THC) is the main 
component of cannabis, and it has a low toxicity, however, chronic usage 
can cause damage to the liver and other organs and impairment of 
attention and memory. [9,10] The main metabolite of THC is 11-nor-delta 
9- tetrahydrocannabinol carboxylic acid (THC-COOH) which can be found 
in blood, urine, hair, sweat, and oral fluids. (Figure 1.4) The drug is usually 
detectable from one to 10 days depending on the type of biological 
sample. [10] Marijuana metabolites have a 50 ng/mL cutoff in screening 
tests and a 15 ng/mL cutoff in confirmation tests. [11]   
 
Cl
NHCH3
O
Ketamine
N
PCP
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Figure 1.4. Pathway of THC metabolism. 
 
(5) Opioids 
The basic structure of opioids contains an aromatic core along with basic 
moieties.  Codeine and morphine have a similar structure, and they are 
Schedule II controlled substances. (Figure 1.5) Both are extracted from 
the opium poppy as opiate alkaloids and are classified as phenanthrenes.  
Opioids have major pharmacologic effects on the CNS because they have 
selective binding sites at several receptors.  Codeine is a weak µ and κ 
agonist, while morphine is a strong µ agonist and a weak κ and δ agonist.  
They both can block the transmission of painful stimuli. [10]   
 
 
Figure 1.5. Structures and Metabolism of codeine to morphine.   
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The primarily metabolites of morphine are morphine-3-glucuronide (M3G) 
and morphine-6-glucuronide(M6G).  Codeine converses to morphine in the 
liver via cytochrome P450 enzyme CYP2D6. [10] Approximately 10-20% 
of unchanged codeine is excreted in the urine in one day.[9]  The 
analytical cutoffs for presumptive and confirmatory testing are 2000 
ng/mL. [11]   
 
b. Forensic Applications of Drugs Analysis  
Typically, there are two steps involved in forensic drug analysis, 
presumptive and confirmatory testing. [14] A presumptive test is used to 
quickly identify the presence of a drug substance while a confirmatory test 
is used to identify and quantify the presence of a target drug.  In general, a 
presumptive test is less specific and mainly detects drug classes while a 
confirmatory test utilizes spectroscopic and chromatographic methods for 
a compound specific determination.  These tests are described and 
standardized by an official organization known as the ‘Scientific Working 
Group for the Analysis of seized Drugs’ (SWGDRUG).  The SWGDRUG 
has published a list of recommendations to assist forensic analysts with 
analytical techniques, protocols and policies.  The most recent version of 
these guidelines was updated in June 2016 as Version 7.1. [15] These 
recommendations cover the practices of sampling, drug identification, 
validation, quality assurance and education.  In this recommendation, 
analytical techniques are classified into three types.  Category A includes 
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infrared spectroscopy (IR), mass spectrometry (MS), nuclear magnetic 
resonance spectroscopy (NMR), Raman spectroscopy and X-ray 
diffractometry; Category B includes capillary electrophoresis (CE), gas 
chromatography (GC), ion mobility spectrometry (IMS), liquid 
chromatography (LC), microcrystalline tests, pharmaceutical identifiers, 
thin layer chromatography (TLC) and macroscopic/microscopic 
examination (only for cannabis); Category C includes color tests, 
fluorescence spectroscopy, immunoassays, melting point, and ultraviolet 
spectroscopy (UV). [15]  In the forensic identification of seized drugs, the 
minimum standards are: (1) if an analytical scheme uses one validated 
analytical technique from Category A, at least another technique from 
Category A, B or C is required; (2) if any technique from Category A is not 
used, at least two techniques from Category B should be examined, and 
one additional test must be performed from Category B or C. [15]  
Depending on jurisdictional requirements, the analytes may be 
characterized as finished products, intermediates, precursors, key 
reagents, or reaction mixtures. [15]     
 
(1) Presumptive Tests 
The purpose of a presumptive test is to determine the potential presence 
of a substance at a crime scene, it is also called a screening test. [12] The 
test can produce a positive, negative, or inconclusive result.  In drug 
analysis, different types of separate presumptive tests are used in the 
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determination of seized drugs and in toxicology. [13] According to 
SWGDRUG Recommendations, color tests and immunoassays from 
Category C, and thin layer chromatography from Category B are used in 
screening tests. [15] Spot tests and thin layer chromatography (TLC) are 
the most widely used methods in seized drug detection while 
immunoassays are generally applied to human toxicological samples.   
Spot tests utilize colorimetric reagents in drug analysis.  These reagents 
are generally selected because of chemical interactions with reactive 
moieties present in the drug. Because of this fact, spot tests lack the 
specificity of spectroscopic methods [13,14] have a relatively high limit of 
detection [13], and can yield false positive and negative results.  Despite 
these weak points, spot tests offer rapid answers under field conditions 
making them highly useful in drug interdiction. [14] The tests do not 
require a highly-trained individual to operate them and generally provide 
quick and useful results.  A typical colorimetric reagent kit contains nine to 
fifteen reagents, and can identify more than 40 of the most common street 
drugs. [13] Once a positive result is obtained, subsequent analytical 
techniques from Category B and A are required to confirm the drug 
determinations. [15] 
More sensitive presumptive detection of toxicological samples can be 
performed via immunoassay.  Immunoassay is an analytical technique 
which can detect and qualify the target analyte based on binding to 
specific antibodies.  In drug analysis, immunoassays are used to detect  
  11 
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target drugs in biological matrices. [10] Although Immunoassays higher 
specificity and a lower limit of detection than spot tests, they have some 
shortcomings. Of most importance is the cross-reactivity, especially for the 
metabolites and drugs of similar structure.  Cross reactivity can cause 
false positive results, particularly when non-controlled substances at high 
concentrations react weakly with the test. False negative results can also 
occur due to interfering substances in the sample matrix.  Another problem 
with immunoassays is the administrative detection cutoffs.  The response 
to each drug can vary depending on the design and manufacturer of the 
test. [13,17]  
 
(2) Confirmation tests 
All positive results from a screening test require further confirmation. 
Confirmation tests utilize a different analytical principle which has higher 
specificity and greater sensitivity than screening tests. [13] The tests 
commonly utilize separation methods to separate the drugs from samples, 
and spectroscopic methods to quantify and identify the components in the 
sample. [9] GC/MS and LC/MS are the most common methods used.  For 
seized drugs, spectroscopic techniques such as FTIR may also be utilized. 
[10,15]  
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2. Research Goals  
In forensic analysis, presumptive tests for drugs of abuse may be 
performed on-site or in a laboratory setting.  On-site and point-of-care 
testing are important to prescreen samples because of the increasing 
laboratory backlogs for confirmatory testing.  Colorimetric tests and 
antibody-based lateral flow immunoassay have been used for years, 
however they generally lack multiplex capabilities. Thus, several tests are 
required to determine the range of potential analytes.   
The goal of the present project was to improve the specificity and 
sensitivity of screening tests through the development of a paper-based 
microfluidic device for drug detection.  Such tests should be inexpensive, 
simple to use and rapid in response.  Two different paper-based 
microfluidic devices were developed.  The first device adapted colorimetric 
tests to a paper format.  Potential analytes included seized drug samples 
such as opiates, cocaine and amphetamines.  The second type of device 
developed for on-site detection of cocaine used a gold 
nanoparticle/aptamers complex based on the principles developed in 
lateral flow immunoassays.  
The colorimetric reagent-based paper microfluidic devices utilized 
modified colorimetric reagents with paper chips.  Since individually these 
tests do not produce high specificity, a multi-channel device can help to 
confirm the presence of the target compound through a simultaneous set 
of cross-comparisons.  Multiple channel also permit a simultaneous 
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determination of different classes of drugs. For example, in such a device, 
a drug could react with 3 or more of the differing spot tests on a single 
device, greatly improving specificity.    As current spot tests are solution 
based and often involve harsh acids reacting with metal salts, the 
experimental work also included the development of a set of reagents that 
utilize alternative oxidants.  The overall goal of these studies was to 
produce reactions that enhanced the color changes on the devices without 
destroying the paper matrix.   
A gold nanoparticle/aptamer based paper microfluidic device was also 
developed to utilize anti-cocaine aptamers as an alternative to the 
antibody based lateral flow immunoassays that are currently used.  
Aptamers are useful alternatives to antibody-based assays as they have 
high affinity and specificity to the target molecule.  Aptamers are DNA or 
RNA based oligomers, and they can be chemically synthesized and 
modified for use with a variety of colorimetric schemes as biosensors.  
Gold nanoparticles change colors resulting from their morphology in 
solution (dispersion vs aggregation).  Gold nanoparticles easily change 
from red to blue under salt-indicated aggregation.  The principle of salt-
induced color changes of gold nanoparticles can be used to increase 
specificity and decrease the limit of detection in the detection of cocaine 
and other drug targets.   Overall these projects have great potential to 
provide improved forensic determinations in on-site drug detection, making 
the analyses simpler, more specific and easier to use. 
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Chapter 2. Paper microfluidic devices  
1. Introduction 
Paper microfluidic devices (µPADs) are patterned paper based analyzers 
which are designed for use as point-of-care diagnostic devices.  
Hydrophobic barriers on the paper channel solvents and analytes to 
specific detection regions.  Originally, these devices were developed for 
use in third world countries where the lack of refrigeration and power for 
instrumentation limited diagnostic capabilities.  Instead, for µPADs, 
reagents are stabilized by being isolated and dried on the paper.  They are 
then activated as the analyte solution moves up the paper, creating a 
system of coupled linear reactions which ultimately result in a color 
change as a positive response.  No external power is needed.    As a 
result, diagnosis can be performed at much lower cost. [1]  
The development of such microfluidic systems for laboratory analysis has 
the potential to revolutionize analytical procedures, bringing laboratory 
operations to the field, and increasing convenience.  Microfluidic platforms 
can be divided into five groups depending on the method of sample 
mobility and fluidic control.   These include methods related to capillary 
action, hydrostatic pressure, centrifugal force, electrokinetic mobility and 
acoustic forces. [2]  Paper microfluidic devices are one type of microfluidic 
platform, they use capillary and electrokinetic methods for the movement 
and analysis of the target of interest. [3]     
Paper microfluidic devices utilize paper as a substrate material.  The 
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development of paper-based chemical testing traced back the work of 
Műller and Clegg in the 1940s, who developed paper chromatography.  
The usage of paper did not get much attention until Martinez et al. 
developed the first paper microfluidic device for chemical analysis. [4] The 
first PAD took advantage of unique properties of the hydrophilic channels, 
permitting the movement of the sample in a designated direction, resulting 
in colorimetric detection at low cost.   Since then, there has been an 
explosion in the development of applications for paper microfluidic 
devices, and many studies of the properties of the paper substrate. [4] 
Paper microfluidic devices are small, flexible, portable, and inexpensive to 
use.  They consume minimal volumes of analytes and reagents and can 
be easily stored for long periods of time.  The devices have been used in 
spot tests and lateral flow analysis methods with chemical and 
biochemical targets. [3]   
 
Figure 2.1 An early design for a paper microfluidic device used in 
bioanalysis.  The device contained detection systems for both glucose and 
protein, with each assay having two detection channels.  (A) The multi- 
channel design of a µPAD used to detect glucose and protein in urine. The 
1	mm
1	mm
glucose assay protein assay
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figure shows the design of channels and barriers. (B) The color changes 
produced by urine applied to the paper-based microfluidic device. When 
the urine sample contained glucose and protein, the channel of the 
glucose assay turned reddish brown and that for the protein assay turned 
green. [1] 
 
 
A. Paper 
Paper can perform capillary action without pumping, improve detection 
limits resulting from its high surface area-to-volume ratio, and retain 
chemicals within the fiber network. [3]  The capillary flow that moves 
through a µPAD is a wicking-based flow, so the wicking rate of paper is an 
important parameter.  Chemicals prepared on µPADs consist of different 
types of materials and the durability of the paper is also important.  
Therefore, the choice of paper depends on the application and the target 
of analysis.  
 
B. Types of µPADs 
There are two types of paper-based microfluidic devices: on-demand 
devices which are blank platforms without pre-deposited reagents; or 
ready-to-use devices, which are designed as complete systems by prior 
deposition of reagents into the designed zones of the device. [3] The 
ready-to-use devices are used to detect specific analytes in samples.   
 
 
 
  20 
C. Preparations and Applications of uPADs 
Manufacturing of paper microfluidic devices is very simple and cheap with 
an estimated price is < $10 per square meter, even using high-quality 
chromatography paper.[1,3,5]  Recently published methods include 
photolithography, plotting with an analogue plotter, ink jet etching, plasma 
treatment, paper cutting, ink jet printing, flexography printing, screen 
printing, laser treatment and wax printing.[3]  Although each method has 
its strengths and weaknesses, wax printing followed by heat based 
lamination can quickly and easily produce usable devices using a wax 
printer and a laminator.[3,6]   
 
Figure 2.2 A comparison of the result from melting of wax ink barriers on 
chromatographic paper viewing the “front”, “back” and “cross-section” of 
the paper.  Before melting, the wax ink only appeared on the front side of 
the paper; after melting, the wax flowed into the paper (cross-section) and 
was visible passing through the paper onto the opposite side. This created 
a barrier to the movement of the liquid sample. 
 
The wax printing method was invented in 2009 and takes advantages of 
the physical deposition of the wax onto fibrous surfaces for later selective 
 
 
 Front Back Cross-section 
Before Melting 
   
After melting 
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hydrophobization [6].  Figure 2.2 demonstrates an example of wax printed 
lines.  The devices’ patterns can be easily designed and adjusted, 
producing devices that are portable, small, and inexpensive.  The 
procedure used to create these devices are divided into two steps: (1) the 
wax patterns are printed on the paper, (2) the wax is melted so that it 
spreads horizontally and vertically into the paper.  The vertical spreading 
creates a hydrophobic barrier within the paper.  A byproduct of the 
process is a horizontal spreading that decreases the resolution of the 
printed pattern, and leads to the wider hydrophobic barriers than the 
original printed patterns. (Figure 2.2) This wax printing method has been 
successfully used in screening for metal ions [7] and pharmaceuticals 
[8,9].  
Capillary flow is the basis of the mobility of fluids in μPADs.  The 
movement can be adjusted by changing the spatial structures and raw 
materials during manufacturing.  For example, Li and co-workers (2008) 
used plasma treatments on μPADs for use in cellulose-based mechanical 
switches, filters and separators. [10] The authors prepared chemically 
treated filter paper, then used metal masks to produce hydrophilic patterns 
via plasma treatments.  The plasma treated areas then permitted capillary 
flow.   
μPADs have been mostly used in biochemical analysis, as well as in 
medical and forensic diagnostics.  The latest tendency in the development 
of these devices is the production of three-dimensional μPADs which can 
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be utilized in colorimetric detection and electrochemical detection in the 
same paper chip. [11] The application of lateral flow paper 
chromatography increases the specificity of μPADs. [4]   Most μPADs 
utilize colorimetric assays, while others focus on chemiluminescence and 
electrochemiluminescence detection techniques. [3]  
Above all, paper-based microfluidic devices have many advantages, such 
as low material costs, a simple production process, simple designs and 
easy interpretations of test results.   There is often no requirement for 
external instruments or instrumentation. These devices are useful in point-
of-care detection of disease, in forensic analysis and in environmental 
monitoring.   
 
D. Color Detection 
In this project, all tests involved colorimetric detection and the results were 
recorded as the pictures for the later instrumental analysis.  The color of a 
substrate is dependent on the pigments used and the diffuse reflectance 
of the colored substrate.  The measured signal is produced by the quantity 
of incident light that is diffusely reflected by the colored reagents in the 
visible range. [12] The observed color is the wavelength of incident light 
that is reflected from the substrate, the other visible wavelengths are 
absorbed.   
Absorbance measurements are described by the Lambert-Beer law for the 
determination of quantities of a sample in solution.  When paper is used as 
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an alternative to solution measurements, the Lambert-Beer law is modified 
to predict the diffuse reflectance of a light beam on a surface as a function 
of the quantity of a colored species detected.  The equation [13] is shown 
below: R = 𝐼$/𝐼& = 𝑅(𝑒*+,- 𝐼$ = 𝐼. + 𝐼0 + 𝐼1 
in which, R = the reflectance of the incident light by the surface; Ir = the 
intensity of the reflected light which depends on the surface of the carrier; 
I0 = the intensity of the incident light; Rw = the reflectance of the reference 
white surface; k1 = a proportionality constant; m = the mass per unit area 
of the substance of interest; Is = the reflection on the surface of the 
solution, in the paper test, the value is assumed as a constant; Ic = the 
reflection on the white surface of the paper; Ip = the reflection on the 
surface of the colored reagent. 
Visual identification is dependent on the perception of color by human 
beings.  Humans have three cone cells in the eyes reflecting short, middle 
and long wavelengths. [14] Paper is a scattering material, thus when 
colored ink is placed on paper, people observe color because the light is 
reflected through the fibers and produces a diffusely-scattered result. [14] 
The perceived color of the dyes on the paper results from the wavelengths 
of incident light that are reflected following the absorbance of the analyte. 
[15] 
For color detection methods utilizing cell phones, digital cameras, or 
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scanners, quantitative detection is based on reflectance. [16, 17]   Usually 
the entire sensing area is used to measure the digital color values for the 
calculation of calibration curves [18].  RGB intensities are the most 
common values used in quantification [19] while chromaticity (hue and 
colorfulness) is another choice [20].   
It is important to note that humans have varying sensitivity to the color.   
Thus to standardize color detection, the idea of a RGB color space was 
created to describe the physical color perceived by human eyes with 
normal vision.[16]  In general the value for red, green and blue as well as 
the brightness are used to describe the color components in an image. 
[16] In this work, the estimation of the RGB values in a colored image, was 
performed using Image J software.   Image J software is an open source 
software program used to analyze images based on color, pixel value, 
angles, and distance.  In particular, Image J RGB Measure Plus software 
was developed to measure the value of single components of red, green 
and blue with a user selected area from a colored image. [17] This 
software permits a computer based verification of images taken during the 
user’s observation of a color change on the device.   It also provides an 
instrumental based confirmation of detection. 
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The overall goal of the current project was to develop multiplexed paper-
based microfluidic devices for forensic drug detection.  The novel 
development of paper microfluidic devices for drug screening can serve as 
a replacement for current colorimetric detection techniques.  The key issue 
in this project was to modify existing solution-based colorimetric methods 
to permit paper-based detection.  In addition, tests for interfering 
compounds and drug diluents were performed as well as an estimation of 
instrumental minimum detectable quantity (MDQ) for the multiple channel 
design. 
 
3. Chemicals and Methods 
A. Chemicals  
All chemicals were analytical grade. Cobalt thiocyanate was purchased 
from Aldrich. Cocaine and ketamine were purchased from Sigma (St 
Louis, MO).  Gold (III) chloride trihydrate (≥ 99.9%) was purchased from 
Sigma-Aldrich (St Louis, MO).  Sucrose, acetone, chloroform, methanol 
and methylene chloride were purchased from Fisher Scientific (Fair Lawn, 
NJ).  Solid wax inks were purchased from Xerox (Norwalk, CT) 
 
B. Preparation and operation of μPADs 
The paper microfluidic devices were printed on chromatographic paper 
using a Xerox wax-ink printer (Xerox ColorQube 8570). The paper was 
next wrapped in aluminum foil and allowed to pass through a laminator at 
2. Goals 
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160˚C from two to five times to infuse the ink into the paper and create 
hydrophobic fluidic barriers.  The colorimetric reagents are then placed at 
the designed positions along the fluidic path, and the drugs are spotted in 
organic solvents at the bottom of the chip. (Figure 2.3)   
 
 
Figure 2.3. Preparation of μPADs.  Step 1: Designing via a software 
Drawer in Windows system.  Step 2: Printing with a chromatographic 
paper through a wax-ink printer.  Step 3: Heating through a laminator at 
160°C for several times.  Step 4: Depositing reagents in the designed 
positions.  Step 5: A ready-to-use μPAD. 
 
The analysis was performed by spotting the dissolved drug onto the chip 
or by placing the chip into a solution of the dissolved drug to allow capillary 
action to carry it up to the various reaction zones as depicted in Figure 2.4. 
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Dropping(
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Figure 2.4.  Operation of ready-to-use μPADs.  The μPADs sat in the vial 
containing the moving solution and drug samples.  The test stops when 
the solution moves to the end of a channel, the operation takes five to ten 
minutes. 
 
4. Results and Discussion  
A. Effects of µPADs  
The channel size and length strongly affects colorimetric development on 
µPADs.  In this work, it was important to adjust these parameters to 
optimize sensitivity and development time.  For example, the size of the 
chip was important in optimizing analysis time.  The longer the channel, 
the longer the running time of the paper chip with the same moving 
solution.  Furthermore, channels facing in a direction counter to the 
upwards liquid flow took much longer for the analyte solution to reach the 
end of the channel.  Depending on the mobility of the solvent, the resulting 
analytes may not reach the reaction zone in such designes.  These design 
considerations must be combined with the chromatographic retention and 
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mixing effects as the solvent front hits each reagent zone.  Thus, there are 
many critical design issues to consider when optimizing µPAD 
development.  Figure 2.5 is an example of the effect of the width of 
channel on the mobility of the solvent as it delivers the colorimetric 
reagent.  Gold nanoparticles moved in the desired channels and crossed 
the barriers when the top channel was much thinner in Figure 2.5, A and 
B.  The same gold nanoparticles moved through the channel but these 
nanoparticles did not cross the barriers when the channel was wider as 
shown in Figure 2.5, C and D. 
 
                    A                    B                             C                  D 
Figure 2.5. The width of moving channels affects the mobility of gold 
nanoparticles on µPADs.  Left: A thinner channel permits movement of 
nanoparticles in 0.3M sucrose solution, the gold nanoparticles crossed the 
barriers to the white part on µPADs.  Right: A wider channel reduces the 
crossing of gold nanoparticles on µPADs.  
 
The saturation of the melted wax into the paper creates a hydrophobic 
barrier on the µPADs. Insufficient melting decreases the hydrophobic 
properties of the barriers and the moving solution will again cross the 
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barrier (Figure 2.6) Therefore, it is critical to optimize the heat of the 
laminator. 
 
Figure 2.6.  Effect of melted wax barriers on µPADs design.  A: Fully 
melted wax barrier. When the moving solution passed through the 
channel, the solution did not cross barriers in a properly prepared µPAD.   
B:  Incompletely melted wax barrier.  When the moving solution passed 
through the channel, the moving solution leaked across the barrier, 
affecting the signal. 
 
The width of the melted ink barriers is also critical.  The purpose of the 
wax barrier is to prevent the solvent flow outside of the barriers, however 
when the barrier was thinner than 0.5mm, the solution crossed over the 
barrier and spread over the surface of chips. (Figure 2.7) Optimal widths 
ranged from 0.8mm to 1mm.   
 
Figure 2.7.  The width of barriers affect the control of solvent movement on 
the µPADs.  When the width of barrier is less than 0.5 mm, the moving 
solution can cross the barrier.   
A B
Color%barrier%width:%0.3mm% %% %%
Color%barrier%width:%0.9mm%%% %%%%%% %
!
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B. Paper 
The whiteness of chromatographic paper is a good background for 
colorimetric detection.  However, chromatographic paper is quickly 
degraded by concentrated acids, creating burned areas and dark spots.  
Only diluted acids are compatible with chromatographic paper.  For 
example, 96% sulfuric acid must be diluted to a concentration of 60% or 
lower, 56% nitric acid to a concentration of 50% or lower and 37% 
hydrochloride acid must be diluted to 35%.  However, when these 
concentrated acids were diluted with water, most colorimetric reagents 
containing strong acids did not produce a chemical reaction.  To avoid this 
problem, we attempted to use glass fiber filter paper (GF/A, GF/C and 
934-AH.)  While concentrated sulfuric acid still digested glass fiber paper, 
concentrated hydrochloride acid and nitric acid could be used. However, 
these three glass fiber filters were too soft to print wax ink on them, and 
capillary flow was not optimal.  Thus, we needed to develop alternative 
reagents/compositions for this application instead of the standard reagents 
used in forensic and TLC analysis. 
 
C. Solutions   
Traditionally, spot test analysis involves the analysis of target drugs 
dissolved in chloroform or methylene chloride in spot tests.  To transfer the 
colorimetric tests to µPADs, methylene chloride and chloroform were 
initially used as carrier solvents.  However, the wax on µPADs dissolves 
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and spreads when acetone, methylene chloride and chloroform move 
through the channel. Methanol dissolves much less ink wax, but it 
evaporated before moving to the end of a long channel.    Water is the 
best solvent so we examined the potential of aqueous/organic solvent 
mixtures.    When acetone is mixed with water at a ratio of 50% and 25%, 
the wax barriers remained stable.  Acetone was preferable as unlike 
methanol it did not produce color changes in the colorimetric test results.  
Therefore, paper-based microfluidic devices can utilize wax-inked 
chromatographic paper and solutions of acetone/water.   Moving solutions 
used with gold nanoparticle/ aptamer based paper microfluidic devices 
were aqueous, containing only salt and sugar as additives. These mixtures 
did not affect the solubility of wax ink on the paper chips. 
 
D. Flow rates 
Flow rates on µPADs are dependent on the width of the channel and the 
type of moving solution.  Four different sizes of chromatography paper 
were tested to determine the range of flow rates using a variety of solutes. 
(Figure 2.8) In general, the wider the channel, the faster the flow rates on 
paper.  Pure water has the fastest flow rate on paper chips.  When salts 
and sugars were dissolved in the moving solutions, the flow rates 
decreased.  The solutions at higher concentrations produce lower flow 
rates.   
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Figure 2.8 Tests of flow rates with different sizes of paper chips and 
different moving solutions.  
 
 
Figure 2.9 Run time of different moving solutions on a channel with a width 
of 0.5 cm.  Water produced the lowest moving time on the paper. 
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Figure 2.10 Run time of different moving solutions as channel width was 
changed from 1 to 3 cm.  The greatest effect was seen at for the solution 
containing the highest salt concentration.   
 
E. Capillary action  
To enhance color developments on the µPADs, colorimetric reagents are 
used at a much higher concentration on the µPADs than in solution tests.  
The solvent migrates via capillary action in a forward direction and the 
color changes occur as reagents are mobilized and mixed together with 
the analyte in the reaction zone.  However, when concentrated reagents 
are used it is possible that   osmosis can occur, with the result that 
reagents may also flow counter to the moving channel.  This effect can 
produce color changes in the solution channel instead of the detection 
zone. (Figure 2.11, Left) A wider solution channel can decrease the 
backflow of the reagent to the solution channel. (Figure 2.11, right) 
Therefore reagent concentration is a critical parameter to avoid backflow 
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due to osmotic effects, and the effect of backflow can be decreased 
through modification of the width of moving channel.   
 
(a)                                   (b) 
Figure 2.11 Backflow of colorimetric reagents. (a) Left: The pink reagent 
moved from the top ball back to the end of the moving channel; Right: the 
color change reaction occurred in the moving channel instead of in the 
reagent ball; (b) Left: The pink reagent moved little from the top ball into 
the moving channel; Right: The color change again occurs in the solvent 
channel. The thinner channel (Left) has a greater backflow effect than the 
wider channel (Right). 
 
5. Conclusions 
A number of different factors affect the colorimetric detections on µPADs.  
The optimization of ready-to-use formats and the applications are related 
to the designs, ink wax, moving solutions and reagents.  The optimal 
format considers the shape, size, direction of channels.  Chromatographic 
paper is a good substrate to the colorimetric detection, and a well-
prepared pattern contained a fully melted wax ink.  The moving solution 
should be safe to the melted wax on µPADs.  To minimize the moving 
time, the main moving channel should be as wide as the design possible, 
meanwhile, the moving solutions should have a low concentration; the 
barriers keep 0.5 mm or higher. 
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Chapter 3. Colorimetric reagent based multiple channel paper microfluidic 
devices  
1. Introduction 
A. Spot Tests 
Colorimetry is defined as a method in which the analyte reacts with a 
proper reagent and produces a unique and visible colored product. [1] It is 
used in qualitative analysis to identify the presence of analytes in simple 
and complex matrices.  The observation of colors is subjective, so the 
operators usually require reference standards to compare with the results.   
A spot test is an important type of the colorimetric measurement used in 
the preliminary identification of seized drugs. [2]   A series of reagents are 
used to react with a single atom or functional group.  For example, the 
Marquis test causes a yellow-brown color with nitrogenous bases and the 
Simon’s test produces a blue color with a secondary amine. [1] 
Colorimetric reactions have been known for many years, many of which 
have been developed for 30, 40 [3] or even up to 70 years [4].  Some 
reagents were developed to detect a single chemical, but they more often 
react with multiple compound or materials.   
In 1987, the Division of Narcotic Drugs invited an expert group to 
summarize a list of colorimetric tests with seized drugs, including details 
on the mechanisms and cross reactants. [5] The listed procedures include 
methods for the detection of opium, morphine, codeine, methadone, 
amphetamines, cannabis, barbiturates, diazepam and benzodiazepine 
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derivatives, lysergide, cocaines, phencyclidine, and others. [5] Later in 
2000 the National Institute of Justice, Law Enforcement and Corrections 
Standards and Testing Program published a standard of the Color test 
reagents/ kits for preliminary identification of drugs of abuse. [6, 7] The 
standard listed the preparation of 12 colorimetric reagents (Table 1) and 
the color changes that occur in the presence of illicit drugs and 
adulterants, the drug detection limit, and the safety of the chemicals.  The 
in-laboratory preparation of spot tests is more common in research labs 
than in government labs where, because of the necessity for validated, on-
site measurements, the operators use colorimetric reagents from kits sold 
by various manufacturers.  The reagents are stored in closed tubes or 
vials and the operator follows specified procedures, adding the samples to 
two or three tubes and observing the color changes.  Results are read 
using the colorimetric charts to minimize the possibility of false positive 
detection of the drugs. (Figure 3.1) 
Spot tests have been used for years in presumptive drug testing because 
they are rapid and inexpensive, however, they have several 
disadvantages. Most importantly, spot tests have low specificity as they 
mainly react with functional groups on the compound of interest [1, 6, 7, 9].    
This characteristic can result in false positive results with other members 
of a drug class or common powders. [7] Thus it is important that the 
results of these tests be verified using more specific techniques to avoid 
improper prosecution of innocent individuals. [10] Because these tests 
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Figure 3.1.  A flow chart for colorimetric drug analysis. [8] The boxes 
indicate the color change possible with each specific drug.  The Marquis 
reagent is used in the first step which produces a specific color change for 
five different drugs, while the white boxes indicate negative results.  
Scott’s reagent is used in the second step, with a pink color indicating 
negative results, and a blue color indicating a positive result.  The Chen-
Kao reagent is the third test, with a purple color indicating a positive result 
and a blue color indicating a negative result.  Libemann’s reagent is used 
in the fourth test, and the yellow color indicates a positive result.  Simon’s 
reagent is used to further differentiate compounds which are positive for 
the Marquis reagent.[ 
 
also have a lower sensitivity than other screening methods, most 
applications focus on seized drug analysis instead of toxicological 
detection. [2, 7] Many colorimetric reagents contain concentrated acids 
(96% H2SO4, 68% HNO3, 37% HCl) and toxic organic solvents (Table 1) 
[6, 7].  For example, in the Duquenois -Levine test, chloroform, a suspect 
carcinogen and liver toxin is used to extract drugs from the reagent to 
display a color change [6].  Because such tests are often accessed by 
poorly trained individuals, more convenient and safer procedures are 
needed.  
Suspected	Solids
Positive
Methylenedioxy-substituted	 cathinones
Amphetamines
Opiates
Ring-substituted	amphetamines	or	methorphan
Nexus
Negative
Positive PositiveNegativeNegative
AmphetamineMDA	or
Methoprhan
MAMA/MDEA/MBDB Methamphetamine
+	Marquis	Reagent
Inconclusive
Scott’s	Reagent	+
NegativePositive
Cocaine
Chen-Kao	Reagent	+
+	Simon’s	Reagent +	Simon’s	Reagent
(Pseudo)ephedrine
Positive
Negative
Negative
Positive
Libermann’s Reagent	+
Cathinone	Analogue Inconclusive
Inconclusive
Inconclusive
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B. Drug detection  
Each colorimetric reagent has their mechanism and targets.  Some 
reagents are designed to detect a single drug; others are available to 
several drugs Commonly, Mayer, Wagner, and Dragendorff reagents can 
detect alkaloids.   For example, the Marquis reagent detects opiates, the 
cobalt thiocyanate reagent detects cocaine, Duquenois reagent and the 
Fast Blue B reagent detect Marijuana. [9] In this project, an effort was 
made to produce colorimetric detection on a heterogeneous paper based 
device by modifying and applying these solutions based reagents to the 
solid support.   Key issues included optimization of reactants to permit 
drug determination without damaging the paper substrate, as well as 
producing a format where the reagents can be isolated and stabilized prior 
to analysis. 
 
a. Cocaine detection 
In spot tests, cocaine HCl in chloroform produces a greenish blue color 
with cobalt thiocyanate and HCl, or produces a dark orange-yellow color 
with cobalt thiocyanate dissolved in water. These tests are performed 
using the Scott reagent, a mixture of 2% cobalt thiocyanate in water and 
glycerine (v:v=1:1).  Cocaine reacts with both cobalt thiocyanate reagents  
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to produce a blue complex from an initially pink solution.  The chemical 
mechanism [5] is as follows: 
[Co(SCN)(H2O)5]+ + 3SCN- + cocaine ↔   Blue complex   
                                                                     
The generic cobalt thiocyanate produces a similar greenish blue color with 
heroin HCl, propoxyphene, hydrocodone tartrate, and another 54 drugs in 
the chloroform solution. [3] Therefore, the Scott reagent was developed 
which is more specific for with cocaine. [11] Houck has mentioned that the 
blue-color changes can turn back to pink after adding concentrated 
hydrochloride acid, and will turn to blue again if a chloroform extraction is 
performed. [11] Deakin reported that cobalt thiocyanate produced a blue 
color with cocaine HCl, but no color changes with cocaine free base. [12] 
Only the addition of concentrated acids lead to a blue color for free base 
cocaine using this cobalt thiocyanate reagent.  
The Mandelin reagent is a mixture of ammonium metavandate and 
concentrated sulfuric acid. The fresh reagent has a strong yellow color.  It 
reacts with more than 100 drugs and the resulting final products yield a 
variety of colors.   For example, a brilliant orange-yellow color is produced 
with methylphenidate and an orange color with ketamine. [3]    
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b. Ketamine detection 
The Mandelin reagent also works with ketamine and the color change is 
from yellow to orange [7], but the Mandelin reagent has a high toxicity.  In 
2013 Gupta et al. modified the cobalt thiocyanate complex with bases to 
permit the colorimetric detection of ketamine hydrochloride. [13] The 
cobalt (II) complex reacts with the thiocyanate to an octahedral complex of 
[Co(SCN)4]2-, and the complex is stabilized by the two hydrophobic cations 
in the coordination sphere. (Figure 3.2)   
 
 
 
Figure 3.2. Mechanism of Cobalt thiocyanate complex reacting with 
ketamine. [13] 
 
c. Codeine/ morphine detection 
Both Codeine and morphine are alkaloids extracted from opium.  The most 
common spot tests for these opioids include concentrated nitric acid, ferric 
sulfate, Marquis reagent, Mecke’s reagent [5], and Froehde reagent [6]. 
Opioids can react with concentrated nitric acid and the final products are 
[Co(SCN)(H2O)5]+(aq) + 3SCN-(aq)               [Co(SCN)4]2-(aq) + 5H2O
[Co(SCN)4]2-(aq) + KOH + 2
Cl
H2N
O
Cl
HN
O
2
Co(SCN)4
Complex
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nitrated opioids which form a hydrogen bond between the nitro group and 
the hydroxyl group. [5]  Nitrated morphine produces an orange-red color 
while nitrated codeine produces an orange color.[5]  Ferric sulfate has a 
positive reaction with the meconic acid in opium resulting in a purple color 
change. [5, 6] The Marquis reagent produces a purple color with both 
morphine and codeine. [6] (Figure 3.3) Mecke’s reagent when mixed with 
codeine and morphine produces a dark bluish green color. [7] (Figure 3.4) 
 
Figure 3.3. Mechanism of Morphine reacting with Marquis reagent.[14] 
 
Figure 3.4. Mechanism of Morphine reacting with Mecke’s reagent.[5] 
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Froehde’s reagent (Table 3.1) is used to detect the benzomorphan class 
of alkaloids, especially opioids.  It turns a dark green color with codeine 
and a dark purplish red with morphine. [6] The mechanism is not well 
studied, but it produces a color change that ranges from pink to purple 
when applied to alkaloids. [7] Ipecac alkaloids and opium alkaloids react to 
a purple-bluish-violet color using this test. [15]   
 
d. Amphetamine/ Methamphetamine detection 
 The Marquis’ Reagent, sulfuric acid, Simon’s reagent, Simon’s reagent 
with acetone and Vitali-Morin’s reagent are common colorimetric reagents 
for the detection of amphetamines and other amphetamine derivatives. 
The Marquis’ reagent gives an orange color with amphetamine and a 
yellowish green color with methamphetamine. [5, 6] (Figure 3.5) Simon’s 
reagent reacts with secondary amines (Figure 3.6) and gives a blue 
Simon-Awe complex with methamphetamine. [5, 6] Acetone can replace 
acetaldehyde in the Simon’s reagent, this alternative works selectively with 
primary amines. [5] (Figure 3.7)  
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Figure 3.5. Mechanism of Amphetamine (R = H)  and methamphetamine 
(R = CH3) reacting with Marquis’ reagent.[5] 
 
 
 
 
Figure 3.6. Mechanism of methamphetamine reacting with Simon’s 
reagent of aldehyde. [5] 
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Figure 3.7. Mechanism of Amphetamine reacting with Simon’s reagent of 
acetone. [5] 
 
 
 
 
Figure 3.8. Mechanism of methamphetamine reacting with Fast Blue B 
reagent. [5] 
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Additional test reagents include Fast Blue B reagent which has been used 
to detect THC in marijuana [16] (Figure 3.8) and FeCl3 which gives a color 
change from yellow to green with amphetamine. [17] 
Colorimetric reagents are designed to for use with liquid solutions.  When 
these same reagents are applied for use with paper microfluidic devices, 
many are not suitable.  As shown in Table 3.1, most colorimetric reagents 
used in drug testing, such as Mandelin and Marquis reagents, use 
concentrated acids in the solution tests.  However, these acids can 
degrade chromatography paper.  Thus, it is necessary to develop an 
alternative to these strong acids.  Some reagents, like the Zwikker 
reagent, require mixing two solutions to create new complex which gives a 
color change with the addition of specific drugs.  However, this type of 
complex is unstable and typically requires fresh preparation prior to use.  
Other reagents use organic solvents, such as acetaldehyde and 
chloroform.  These organic rapidly evaporate in air, and will also not work 
with paper chips.  The reagents also require modification before they can 
be applied to the paper devices.   
 
2. Goals 
The goal of this project was to prepare a multiple-channel paper chip for 
the presumptive determination of seized drugs.  The project was 
separated into four tasks.  First, the colorimetric reagents had to be 
modified to permit their use with chromatographic paper instead of liquid 
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solutions.  Second, the cross-reactivity and interferences of the modified 
colorimetric reagents on µPADs needed to be cataloged.  Third, an 
estimation of figures of merit including instrumental minimum detectable 
quantity (MDQ) needed to be determined.  Fourth, the final development 
and validation of a multi-channel device for drug detection needed to be 
completed.   
 
3. Chemicals and Methods 
A. Chemicals 
All chemicals were analytical grade. Cobalt thiocyanate was purchased 
from Aldrich; iron (III) chloride and glycerol were purchased from Acros 
Organics (Waltham, MA, United States); fast blue B, molybdic acid and 
ninhydrin were purchased from Sigma-Aldrich (St. Louis, MO, Unites 
States); potassium permanganate, sodium hydroxide, hydrochloric acid, 
and acetone were purchased from Fisher (Pittsburgh, PA, United States). 
Amphetamine, methamphetamine, cocaine, ketamine, ephedrine were 
purchased from Sigma (St Louis, MO, United States).  Morphine, codeine 
and thebaine were purchased from RBI (Natick, MA, United States).  The 
standard solutions of drugs were prepared as 100mg/mL in 50% acetone/ 
50% deionized (d.i.) water. 
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B. Designs of Paper Microfluidic Devices 
A six-channel paper microfluidic device was designed to detect several 
psychotropic compounds as followed: cocaine, ephedrine, morphine, 
ketamine, amphetamine, methamphetamine and MDMA. 
The paper chip was developed following single tests, and each channel 
contained different amounts of the reagent area. (Figure 3.9)   According 
to the final colors, the format used the color of yellow, other colors like 
black, blue, green and red could produce misleading phenomena to the 
naked eyes.  The words next to each channel indicated the possible drugs 
with the positive results for each channel, the color of the terms described 
the positive color changes.  
 
Figure 3.9: Six channel device developed for sample analysis.  The device 
consists of six channels with one or two zones for placing reagents.  The 
solid sample is dissolved in solvent and introduced at the bottom of the 
device using a paper tab placed in a vial.  Alternatively, the solids can be 
added to the middle channel.  Capillary action mobilizes the drug and the 
solvent mixture up into the reaction zones.  Dashed areas indicate the 
image region used for the colorimetric detection by eye or cell phone 
camera.  Cod = codeine, Coc = cocaine, Ket = ketamine, Morp = 
morphine, Amp = amphetamine, MA = methamphetamine, Eph = 
ephedrine, The = thebaine. 
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After the final design was obtained, the format was printed on 
chromatographic paper (Whatman No.1, GE Healthcare, UK) using a 
commercial wax printer (Xerox Color Cube 8570, Xerox, US).  Next, the 
paper was wrapped in an aluminum foil package and passed three to five 
times through a laminator at 160 °C, at a speed of 1.6 cm/sec (Tamerica 
Tashin Industrial Corp, TCC-6000).  The wax melted from the surface to 
the back of the chromatographic paper and created the hydrophobic 
barriers.  
The design of each channel can detect a different set of compounds with 
unique colored responses depending on the modified reagents.  Figure 3.9 
illustrated the design of the chip, and the number indicated each channel, 
and the letters identified the potential locations for each reagent.  Samples 
and reagents were prepared in different locations to optimize the color 
generation, sensitivity, reaction time and system stability. 
Lane 1 (L1 in Figure 3.9) prepared to detect ephedrine, MDMA and 
methamphetamine in unknown samples.  In this lane, 0.5 µL of a mixture 
containing 100 mg/mL sodium sulfate and 10 mg/mL Fast Blue B were 
deposited to zone A.  Lane 2 (L2 in Figure 3.9) was used to detect four 
compounds, cocaine, codeine, thebaine, and ketamine.  Also, 0.5 µL of a 
mixture containing 100 mg/Ml cobalt (ii) thiocyanate and glycerol (v:v=3:2) 
added to zone A.  Lane 3 (L3 in Figure 3.9) could identify codeine, MDMA, 
morphine and methamphetamine.  One mg of potassium permanganate 
was crushed by a spatula onto L3 zone A and 2 µL of 1 mg/µL molybdic 
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acid were added to L3 zone B.  Lane 4 (L4 in Figure 3.9) detected 
ketamine by using 0.5 µL of 0.02 mg/mL of sodium hydroxide in zone B 
and 0.5 µL of 12.5 mg/mL cobalt thiocyanate in zone A.  Lane 5 (L5 in 
Figure 3.9) was designed to detect amphetamine with the separate 
deposition of 0.5 µL of 50 mg/mL ninhydrin in 50% acetone and 1M NaOH 
in zone A.  Lane 6 (L6 in Figure 3.9) detected morphine and MDMA.  0.5 
µL of 100 mg/mL FeCl3 added to zone A.  Finally, the bottom tip of the 
device would be placed in a carrier solution of 300 µL of 50% acetone in 
water, and capillary action would move the drug and the solute to the end 
of each channel.   
 
C. Estimation of instrumental MDQ and visual LOD 
For the solution limit of detection by eye, single lane paper microfluidic 
devices were set in the sample bottles.  The drugs were dissolved in 
acetone:water (v:v=50:50).  When the paper devices were place in the 
bottles, the solutions moved through the channels and produced the color 
changes at the end of the channels. (Figure 3.10)   
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Figure 3.10. A solution test for determination of limit of detection.  The 
cocaine concentrations used in this test were 0, 200 µg/mL, 400 µg/mL, 
600 µg/mL, 800 µg/mL, 1000 µg/mL from left to right. 
 
The calculation of MDQ was carried out using the single lane devices and 
the analysis by software Image J.  The sample bottles contained 
acetone/water solvent. The drugs were dissolved in acetone/water, and 
were placed on the middle of the channel.  When all solutions on the 
paper chips dried, the paper chips were placed in the carrier solution vials 
and the drugs on the paper moved up the chip via capillary flow.  When 
the drug reached the terminal end of channel, the color change 
immediately occurred.  The calculation of minimum detectable quantity 
(MDQ) was performed using pictures recorded by an 8-megapixel camera 
attached to a Nexus 5 (LGE) smartphone.  The microfluidic devices were 
photographed on a white background and with a flash from the 
smartphone camera to avoid the external light contamination.  All paper 
microfluidic devices were kept at a distance of 6 cm between the camera 
and the background.   
The intensity of the red (R), green (G), blue (B) and RGB components was 
used in data analysis by Image J software version 1.48.  Equation (1) 
calculated the proportionality between the color components and the 
absorbance:  
 𝐴3 = −𝑙𝑜𝑔 8989,; = - 𝑙𝑜𝑔𝑅<  (1) 
in which Ax was the absorbance of X, Ix was the intensity of color 
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component, Ix,w was the intensity of the blank spot, Rx was the reflectance 
of light X and C was the concentration of X.   
 
Estimation of MDQs was performed using a modified device in which an 
additional Position A was added to permit the deposition of 0.5 µL of a 
standard sample upstream of the colorimetric reagents.  0.5 µL of a variety 
of standard solutions containing 1 to 100 mg/mL of each drug was added 
to the sample area of each lane (A zones – Figure 3.11) Each test was 
repeated three times.  Quantitative measurements were taken at the end 
of each channel (Position D in Figure 3.11).  The absorbance of each drug 
sample was proportional to the quantity of the drug, and the minimum 
detectable quantity was estimated as three times the standard deviation of 
the intercept divided by the slope of the calibration line.  
 
Figure 3.11. Multi assay presumptive test of a six-lane device for MDQ 
estimation.  Position A: Sample area; Position B, C: Reagent areas.  
Position D: End part.  Lane 1: Modified Fast Blue test. Line 2: Modified 
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Frohdles test.  Line 3: Modified Scott reagent test.  Line 4: Ninhydrin test.  
Line 5: Cobalt thiocyanate/ NaOH test.  Line 6: Modified iron (III) chloride 
test.   
 
D. Interference tests 
Lidocaine and procaine were purchased from Acros Organics (Waltham, 
MA, United States), quinine was purchased from J. T. Baker Inc. 
(Philipsburg, NJ, United States) and caffeine was purchased from Sigma-
Aldrich (St. Louis, MO, United States).  Dimethylsulfone, lactose, mannitol 
and inositol were obtained from Fisher (Pittsburgh, PA, United States). 
King Arthur gluten-free flour, Arm & Hammer baking soda, Publix 
granulated sugar, Rumford aluminum free baking powder, Shower Bath 
Salt absorbent body powder, iodized salt, (Publix antacid tablets), and 
Argo 100% pure corn starch were purchased from supermarkets in Miami, 
FL, United States. Before analysis a solution or slurry of each interference 
was prepared at a concentration of 100 mg/mL in 50% acetone /50% 
deionized water. 
The device used in interference tests used the design in Figure 3.11.  
Each sample was deposited in zone A, and the moving solution of 50% 
water transferred the sample to the end of the channels and produced 
positive/negative results 
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4. Results and Discussion 
A. Modifications of Reagents for SAMHSA-5 drugs 
(a) Modifications of Scott’s reagent for cocaine detection 
The Scott reagent was designed for specific detection of cocaine, but we 
found the reagent produced an incomplete result with cocaine free base in 
the solution test. The original method required the addition of concentrated 
hydrochloric acid and chloroform to create a bilayered extraction and the 
positive color blue color change appeared in the organic phase. Deakin 
found  that cocaine free base itself did not produce a blue color with Scott 
reagents, and cocaine in  both its acidic and free base phases produced a 
blue color change with the addition of concentrated acids.[12]  However, 
concentrated acids, from 98% sulfuric acid, 68% nitric acid to 37% 
hydrochloride, degrade chromatographic paper and cannot be directly 
applied to paper microfluidic devices.  Dilution of the acid was one option.   
Experiments were performed using concentrated hydrochloric acid diluted 
to 24%, 13.5%, 6.5%, and 3.7% with d.i. water.  The result was then 
examined for use on the paper devices.  All solutions produced a blue 
color change with the Scott reagent in the solution tests when cocaine was 
added.  However, when the modified Scott reagent was mixed with 3.7% 
hydrochloride, it produced a positive result with several psychotropic 
compounds including Morphine, MDMA, amphetamine, 
methamphetamine, ketamine, ephedrine, cocaine, codeine, quinine, and 
procaine. 
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Figure 3.12. Blank (left), cocaine (right, 1 mg/mL) was added to the Scott 
reagent (2 g Co(SCN)2, 48 mL glycerol, 50 mL H2O).  
 
In the original Scott reagent test, chloroform is the solvent for the cocaine 
solid.  Chloroform is toxic and a carcinogen, and is a poor choice for 
usage in the field test.  Furthermore, chloroform dissolve the wax on paper 
microfluidic device.  An alternative method involves the use of methanol 
and acetone as a solvent.  These solvents can be mixed with water, 
eliminating problems with dissolution of the wax barriers of the hydrophilic 
channels.  In our design, we utilized organic solvents to adjust the capillary 
action of solutions of drugs on paper microfluidic device.  In our work, it 
was important to catalog differences in color development caused by 
changes in organic solvent composition.  When solid cocaine was 
dissolved in 50% acetone and 50% methanol, the acidified Scott reagent 
still produced a blue color from the red reagent.  An interesting result was 
obtained when the reagent was used with ephedrine.  Deakin reported that 
ephedrine HCl produced a quickly-disappearing light blue color with the 
Scott reagent, and the presence of concentrated hydrochloride can make 
the color change stable in aqueous solution. [12]  We examined the results 
of this test with ephedrine hydrochloride in 50% acetone.   The result was 
a green color, however, when dissolved in 50% methanol, the same 
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reagent produced a purple color.   
                             
Figure 3.13. Color change observed for the modified Scott reagent. Left: 
ephedrine/methanol; Right: ephedrine/acetone.  Ephedrine: 1mg/mL               
 
This reagent did not work with cocaine free base in solution but it did work 
on paper microfluidic devices.  However, the color produced was light and 
difficult to distinguish from the paper background. As a result, a set of 
solutions including 2%, 4%, 6%, 8%, 10%, 12%, 15%, 20% (w/v) cobalt (II) 
thiocyanate were examined for color changes, when the concentration 
increased to 8%, the blue color changes were easy to observe (Figure 
3.14); but when the concentration were higher than 12%, the blue color 
was hidden in the original dark red color.   
 
Figure 3.14. Color change observed for the modified Scott reagent on 
paper microfluidic device.  Left: Blank test.  Right: Cocaine test, cocaine 
1mg/mL in 50% Acetone. 
 
(b) Modifications of basic Scott reagent for ketamine detection 
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The published method for detection of ketamine hydrochloride used 0.1M 
cobalt tetrathiocyanate/ ethylene glycol and 0.1 KOH solution. [12] In the 
solution tests, we prepared a mixture of cobalt thiocyanate and sodium 
hydroxide, and the tests did not work with ketamine hydrochloride.  The 
cobalt thiocyanate appeared as red in the aqueous solution, and it 
changed to green following the addition of NaOH.  Ketamine hydrochloride 
was continually added to the mixture, and the solution remained green.  
We found that additional hydrochloride was necessary to produce the 
same purple color change in the solution tests as the paper described. [13]   
A higher concentration of reagents was next used to increase the intensity 
of the color on paper chips.  The modified thiocyanate reagent was used 
at a concentration of 125 grams/L; the sodium hydroxide was 2% (w/v).  
When the test was applied to paper microfluidic devices, a solution 
containing 10% Co(SCN)2/ NaOH was deposited on the paper (Figure 
3.15, Mid, Zone B), and when the ketamine solution moved up the channel 
to the reagent position, no color change occurred.  A modified design 
incorporating three sequential zoned for reagents was developed to 
optimize this process, (Figure 3.15).  When the Co(SCN)2 was added to 
position C and the NaOH added to Position B, the ketamine sample 
moved through the channel and no color change occurred.  When the 
NaOH solution was deposited on position C and the Co(SCN)2 deposited 
on position B, the ketamine produced a unique purple-blue color in the 
Co(SCN)2 zone. (Figure 3.15, Mid) Dubey et al. described a ketamine test 
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reagent based on the use of a basified Scott reagent.[13]  In this test, the 
order of  addition of the chemicals did not impact the color change.  
However, when used in the µPADs, the ketamine must react with NaOH 
before moving to the Co(SCN)2 area.  The presence of 3.7% hydrochloride 
created a blue-color change under the same conditions.   (Figure 3.15, 
Right) 
 
 
Figure 3.15. Color change observed for the ketamine test.  Ketamine 
(Ket): 50 mg/mL. 
 
(c) Modifications of Frohde’s reagent for codeine detection 
The original Frohde’s reagent consists of concentrated sulfuric acid and 
molybdic acid.  Chromatographic paper cannot survive from the presence 
of concentrated sulfuric acid.  Dilution of the 96% H2SO4 to a lower 
concentration eliminated the colorimetric response.   In general, this test 
did not work when the concentration of acid was lower than 96%.  
Concentrated sulfuric acid is commonly used as an oxidizer or a strong 
acid.  To test the potential that the role of sulfuric acid was as an oxidizer 
and not a proton source, molybdic acid was treated with concentrated 
w/out&HCl w/HCl Blank&&Ket Ket w/HCl
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nitric acid and concentrated hydrochloride acid and used in the test format 
with codeine.  Since neither acid produced a color change, it was likely 
that concentrated sulfuric acid was acting as an oxidizer in the reagent.  
Several strong oxidizers were next examined, however only potassium 
permanganate combined with molybdic acid produced a color change 
when combined with different drugs.  The blank test produced a purple-red 
color which results from the permanganate in the solution.  Following the 
addition of codeine, the color of the solution changed to a brown-yellow 
color.  This brown-yellow color likely results from a complex of molybdate-
oxidized codeine coupled with the manganese ion (Mn2+).  The 
mechanism was assumed as follows: 
Morphine + KMnO4 + MoO3  
–> Mn2+ + MoO42- + Product from oxidation/complexation with codeine 
 
 
Figure 3.16. Color change observed for the codeine test.  Blank (left), 
codeine (right,2.5 ɥM) was added to molybdic acid dissolved in  
KMnO4/acetone at 5 ɥM - 2.5 ɥM). On the paper, oxycodone in acetone: 
H2O (10 mg/mL) was screened using KMnO4 and molybdic acid pastes. 
 
When the test was transferred to the paper microfluidic device, the reagent 
produced a purple-red color.  However, this mixture oxidized in air when 
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deposited on paper changing to red in ten minutes and then continuing to 
oxidize to brown color over a period of one hour.  Even when prepared 
and protected in the sealed packages oxidation occurred within a day.  
However, when the reagent was prepared as a paste, the test worked.  
The order of placement of the reagents on the paper chip was also 
important.  
In these experiments a sample of codeine was dissolved in 50% acetone 
and was placed at the bottom of the chip.   It then moves up the lane via 
capillary action towards the reagent zones.    When the chip was prepared 
by deposition of permanganate upstream of the molybdic acid, the purple-
red color migrates upward, covering all spaces in the chip, making it 
difficult to detect the color change produced by the molybic acid.  
However, if molybdic acid was deposited upstream of permanganate, a 
proper color change was observed.   
 
 (d) Modification of Iron (II) Chloride for the morphine test 
The original iron chloride test involves the reaction of ferric chloride with 
morphine which produces a color change from yellow to green.  Ferric 
chloride was dissolved in water at concentrations of 10mg/mL, 30mg/mL, 
50mg/mL, 700mg/mL, 100mg/mL and applied to µPADs, with the 
deposited reagent appearing as yellow spots at the end of channel (Figure 
3.17, Left). A concentration of 100mg/mL produced the darkest green with 
a morphine sample of 1mg/mL. (Figure 3.17, right) 
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Figure 3.17: Color change observed for the morphine test (right) and a 
blank (mid) 
 
(e) Modification of Ninhydrin for the amphetamine test 
The ninhydrin /NaOH test designed for amphetamine included three steps: 
(1) ninhydrin was dissolved in acetone/water at a concentration of 
50mg/mL and the solution was dropped to the end of the channel and 
dried; (2) a sodium hydroxide solution of 1M was spotted on top of the 
ninhydrin; (3) amphetamine was dissolved in an acetone/water (v:v=50:50)  
1mg/mL of amphetamine in 50% acetone of 300 µL was prepared in the 
carrier vials.  When the paper chip dried, it was placed in a vial, and 
capillary action moved the sample to the end of the channel. The color 
change of amphetamine was from light yellow to purple. 
 
Figure 3.18: Color change observed for the amphetamine test (right) and a 
blank (mid) 
 (f) Modification of Fast Blue B for the MDMA and methamphetamine test 
The Fast Blue B/ Na2SO4 test designed for methamphetamine and MDMA 
!!!!!!!!!!!!!!!!!!!!!!!!!! !
!
!!!!!!! !
!
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included three steps: (1) 1µL of a Fast Blue B solution of 10mg/mL was 
spotted on the end of the channel and dried; (2) 1µL of a Na2SO4 solution 
of 100mg/Ml was dropped to the position of Fast Blue B; (3) MDMA and 
methamphetamine were separately dissolved in a acetone/water 
(v:v=50:50) solution.  A 300 µL of 1mg/mL methamphetamine in 50% 
acetone was prepared in the carrier vials.  When the paper chip dried, the 
paper chip sat in the vials and capillary action moved the sample to the 
end of the channel. The color change of methamphetamine was from 
yellow/brown to orange. (Figure 3.19, upper) 1 µL of 1mg/mL MDMA 
added in the middle channel under the Fast Blue B spot, 50% acetone 
moved the sample to the end of the channel and produced a color change 
from yellow/brown to red/brown. (Figure 3.19, bottom) 
 
Figure 3.19: Color change observed for the detection of 
Methamphetamine (top) and MDMA test (bottom) a modified Fast Blue B 
reagent was used. 
B. Estimation and Determination of MDQ and LOD 
The minimum detectable quantity (MDQ) for the drug detection was 
!
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calculated using the amount of drug necessary to produce a color change 
on each µPAD.  Each test was repeated three times.  Image J software 
was used to calculate the intensity of the red, green, blue and RGB 
components of the area of each reaction (end of each lane – Figure 3.11) 
from the images produced by a Nexus 5 (LGE) smart phone. The resultant 
signals were plotted as a function of the quantity of drug using eqn (1), 
Figure 3.20.  Ephedrine, methamphetamine and MDMA produced the best 
linear relationship using the absorbance of blue components and the drug 
quantity.  Amphetamine, ketamine and morphine respectively produced an 
optimal response with the green, RGB and red component.  The value of 
the instrumental MDQ was estimated as three times the standard 
deviation of the intercept divided by the slope of the calibration curve.   
C. Cross-reactivity and interferences  
Cross-reactivity tests were designed to test the response of the 
colorimetric reagent paper chips with cocaine, ketamine, ephedrine, 
MDMA, amphetamine, methamphetamine, codeine, morphine and 
thebaine.  All color changes were labeled in Table 3.3, and the false-
positive tests of common powders and controlled substances were listed 
in Table 3.4.  The paper chips containing the modified Scott’s reagent and 
the modified Morris reagent reacted with almost all drugs listed in Table 
3.4.  Only ketamine produced a distinct purple color, while the rest of the 
drugs produced a blue color.  Since these two paper chips did not react 
with common powders, they could only be used to narrow the range of 
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types of drugs, but they cannot identify a single drug.  Fast Blue B reagent 
based paper chips only produced results with MDMA, methamphetamine,  
 
Figure 3.20. Application of ImageJ software for the detection of various 
drugs on the µPAD device. Pixel colors are indicated on the Y axis. 
Linearity ranges: (a) amphetamine; (b) ephedrine; (c) MDMA; (d) 
ketamine; (e) morphine; (f) methamphetamine. (n=3) 
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ketamine and procaine.  All gave the same orange color.  The FeCl3 
reagent based paper chips produced different color changes when treated 
with MDMA, ephedrine and morphine.  Ninhydrin reagent based paper 
chips produced results with amphetamine.   
In order to test for interferences, nine commercial products including flour, 
baking soda, sugar, baking powder, bath salt, body powder, table salt, 
antacid and corn starch were tested to determine if false positive 
responses occur. Among the tested products, the baking soda reacted 
with Fast Blue B reagent, turning to brown. Most of the common diluents 
used to cut illicit compounds (quinine, lidocaine, procaine, caffeine, 
dimethylsulfone, lactose, sucrose, mannitol, and inositol did not react with 
test reagents. However, procaine did produce a combination of colors 
close to that of methamphetamine (Table 3.4)    
Additional tests of drugs and interferences with the multiple channel chip 
design were performed by Giacomo Musile (Figure. 3.21). [17] 
  
Figure 3.21 A demonstration of the µPAD developed to detect 
interferences: From left to right: Modified Scott’s reagent channel, 
ninhydrin reagent channel, Fast blue B reagent channel, ferric chloride 
channel, permanganate/ molybdic acid channel.  The results show a 
comparison of a blank chip (left) and a chip exposed to a sample of 
quinine (right), with a resulting change in the color of the modified 
Scott’s reagent.  
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Table 3.4. False positives: Common powder, diluents and adulterants 
 R#1 R#2 R#3 R#4 R#5 R#6 
Blank Solution        
Positive Solution        
Common Powder       
King Artur Flour Gluten Free 
Multipurpose Flour 
NCC NCC NCC NCC NCC NCC 
Arm & Hummer Pure Baking 
Soda 
 NCC NCC NCC NCC NCC 
Publix  Pure Granulated 
Sugar Extrafine 
NCC NCC NCC NCC NCC NCC 
Publix Confectioners Sugar NCC NCC NCC NCC NCC NCC 
Rumford Aluminium Free 
Baking Powder 
NCC NCC NCC NCC NCC NCC 
Shower Bath Salt Absorbent 
Body Powder 
NCC NCC NCC NCC NCC NCC 
Winn Dixie Iodized Salt NCC NCC NCC NCC NCC NCC 
Antacid Tablet NCC NCC NCC NCC NCC NCC 
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 R#1 R#2 R#3 R#4 R#5 R#6 
Adulterants       
Quinine NCC NCC NCC  NCC NCC 
Lidocaine NCC NCC NCC NCC NCC  
Procaine  NCC NCC    
Caffeine NCC NCC NCC NCC  NCC 
Diluents       
Dimethylsulfone NCC NCC NCC NCC NCC NCC 
Lactose NCC NCC NCC NCC NCC NCC 
Sucrose NCC NCC NCC NCC NCC NCC 
Mannitol NCC NCC NCC NCC NCC NCC 
Inositol NCC NCC NCC NCC NCC NCC 
Starch NCC NCC NCC NCC NCC NCC 
 
*R#1: Fast Blue B Reagent; R#2: FeCl3 Reagent; R#3: Ninhydrin 
Reagent; R#4: Modified Scott’s Reagent; R#5: Modified Morris 
Reagent; R#6: Modified Froehde's Reagent.  NCC: no color 
change. 
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Although some of the drugs had the same color change with one reagent 
on the paper chips, the multi-channel paper chips permitted a far more 
specific determination of the unknown compounds through the use of the 
cross-reactivity chart.  Figure 3.22 is an example of an application 
involving the determination of morphine.  For this chip, Lane 3, the 
modified Froehde turned red; Lane 4, the basified cobalt thiocyanate 
turned blue, and lane 6, Fast Blue B turned green.  The rest of the 
channels produced negative results.  Because the chips are printed with 
colored wax, it was easy for the user to determine the result, by simply 
comparing the developed color with that color printed on the device.   
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Figure 3.22: A demonstration of the µPAD developed to detect seized 
drugs: Top - Blank Sample; Bottom- a positive result for morphine. 
Each lane of the device is labeled with the name and color at which 
each analytes should appear Lane 1 ephedrine (Eph), 
metamphetamine (MA) and MDMA; Lane 2 cocaine (Coc), codeine 
(Cod), ketamine (Ket) and thebaine (The); Lane 3 codeine (Cod), 
metamphetamine (MA), MDMA and morphine (Morp); Lane 4 ketamine 
(Ket) and morphine (Morp); Lane 5 amphetamine (Amp); Lane 6 
morphine (Morp) and MDMA. 
 
D. Storage and Stability 
We have examined various methods to enable long-term storage of the 
paper microfluidic chips.  The first method was to save the paper chips in 
plastic envelopes.  After 3 months, only the Co(SCN)2/ NaOH - test and 
modified Scott’s reagent remained effective.  The other reagents did not 
immediately react with drug solutions; however they did produce a color 
change if they sat overnight.  The second method was to seal the paper 
chips within a nylon film pouch.  Since Ninihydrin reagent – paper chips 
changed color after heating during the sealing process, we heated the 
laminar sheets surround the paper chips but did not heat areas where 
reagents were spotted. The paper chips were kept in dark drawers and in 
the refrigerator.  All chips reacted with target drugs after one month.  After 
two months, all reagents produced the expected result in under 5 minutes 
with the exception of the Fast-Blue and ninhydrin reagents.  These two 
reagents required an additional twenty-five minutes to produce a positive 
reaction. 
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5. Conclusions 
Traditional screening tests using colorimetric reagents require a series of 
individual tests to produce a positive result, potentially wasting precious 
evidence and requiring time to manipulate samples and reagents.   These 
traditional tests result in LODs that are above 10 ug, and the total cost for 
analysis is approximately 4 to 6 dollars per test. In this project, a rapid and 
sensitive method using a paper microfluidic device has been developed as 
an alternative to spot tests for the presumptive determination of a variety 
of illicit seized drugs. The device, not much larger than a postage stamp, 
produces observable color changes that are detectable by the naked-eye 
that are sufficient to detect a few micrograms of each compound, in under 
5 minutes. The procedure uses low quantities of reagents in an easily 
stored format and demonstrates improved sensitivity when compared to 
solution based colorimetric testing. The cost for manufacture is minimal, 
approximately 20 cents per device. In addition, since the reagents are 
absorbed onto the paper the procedure is much easier to perform and less 
hazardous to use. The multichannel system permits the simultaneous 
detection of compounds using a variety different reagents. This process 
greatly increases the specificity of the method. The system also permits 
the user to distinguish between illicit drugs, drug diluents and common 
powders. Overall, we expect this procedure to greatly benefit forensic 
testing, customs and other applications where quick portable testing of 
unknown powders is necessary.  
  75 
6. References 
1. Preedy, V. R. Neuropathology of Drug Addictions and Substance 
Misuse Volume 2: Stimulants, Club and Dissociative Drugs, 
Hallucinogens, Steroids, Inhalants and International Aspects. 
Academic Press. 2016. 
 
2. Namera, A., Nakamoto, A., Saito, T., & Nagao, M. Colorimetric 
detection and chromatographic analyses of designer drugs in 
biological materials: a comprehensive review. Forensic 
toxicology, 2011, 29(1), 1-24. 
 
3. Masoud, A. N. Systematic identification of drugs of abuse I: Spot 
tests. Journal of pharmaceutical sciences, 1975, 64(5), 841-844. 
 
4. Kolthoff, I. M. The Cobalt-Thiocyanate Reaction for the Detection of 
Cobalt and Thiocyanate. Mikrochemie, 1930, 8(1), 176-181. 
 
5. Kovar, K. A., Laudszun, M. Chemistry and reaction mechanisms of 
rapid tests for drugs of abuse and precursors chemicals. SCITEC/6, 
United Nations, Vienna. 1989. 
 
6. Fatah, A. A. Color Test Reagents/Kits for Preliminary Identification 
of Drugs of Abuse. NIJ Standard-0604.01. 2000. 
 
7. O’Neal, C. L., Crouch, D. J., & Fatah, A. A. Validation of twelve 
chemical spot tests for the detection of drugs of abuse. Forensic 
Science International, 2000, 109(3), 189-201. 
 
8. Toole, K. E., Fu, S., Shimmon, R., Kraymen, N., & Casamento, S. 
G. Color tests for the preliminary identification of methcathinone 
and analogues of methcathinone. Microgram Journal. 2012.  
 
9. Martinez, A. W., Phillips, S. T., Whitesides, G. M., & Carrilho, E. 
Diagnostics for the developing world: microfluidic paper-based 
analytical devices. 2009. 
 
10. Houck, M. M., & Siegel, J. A. (2009). Fundamentals of forensic 
science. Academic Press. 
 
11. Deakin, A. L. A study of acids used for the acidified cobalt 
thiocyanate test for cocaine base. Microgram Journal, 2003, 1(1-2), 
40. 
 
  76 
12. Dubey, P., Shukla, S. K., Gupta, K. C. Modified Scott's test for 
ketamine hydrochloride. Australian Journal of Forensic 
Sciences, 2013, 45(2), 165-171. 
 
13. Rehse, K., Kawerau, H. G. Mechanism of the reaction of aromatic 
compounds with formaldehyde in concentrated sulfuric acid 
(Marquis reagent)(author's transl). Archiv der Pharmazie, 1974, 
307(12), 934. 
 
14. Fuller, H. C. The Chemistry and analysis of drugs and medicines. 
John Wiley & sons, Incorporated. 1920. 
 
15. Andre, C., Vercruysse, A. Histochemical study of the stalked 
glandular hairs of the female Cannabis plants, using fast blue 
salt. Planta medica, 1976, 29(04), 361-366. 
 
16. Komsta, L., Waksmundzka-Hajnos, M., Sherma, J. Thin layer 
chromatography in drug analysis. CRC Press. 2013. 
 
17. Musile, G.; Wang, L.; Bottoms, J.; Tagliaro, F.; McCord, B., The 
development of paper microfluidic devices for presumptive drug 
detection, Analytical Methods, 2015, 7, 8025-8033. 
 
 
 
 
 
 
 
 
 
 
 
 
  77 
Chapter 4. Gold nanoparticles/aptamers based paper microfluidic device 
designed to cocaine detection 
1. Introduction  
A. Gold nanoparticles 
 For more than 40 years, new uses for gold nanoparticles (AuNPs) have 
emerged within the fields of nanotechnology and nanoscience.  Variation 
in the size and shapes of these nanoparticles result in a wide variety of 
chemical, electronic and optical properties that make them attractive for 
applications in chemistry, biology, physics and engineering.  
a. Preparation of Gold Nanoparticles 
The synthesis of gold nanoparticles can be separated into homogeneous 
and heterogeneous methods.  Homogeneous methods involve AuIII 
reduction in aqueous or organic media followed by surface stabilization to 
minimize aggregation and precipitation. [1] Synthetic methods include 
chemical, photochemical, electrochemical, sonochemical and microwave-
assisted reduction methods. [1]  Chemical reduction is a popular and easy 
method, and this procedure is capable of producing a narrow size range of 
nanoparticles.  For example, the Brust-Schiffrin method utilizes an organic 
phase and can produce 2-10 nm sized using NaBH4 as reductant and 
organothiol as a surface protecting agent. [2]  Alternatively, the Turkevich 
method occurs in aqueous phase and produces 10-20 nm gold 
nanoparticles using citrate both as a reductant and a surface protecting 
agent. [3] Larger nanoparticles (10-50 nm) can be created 
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using ascorbic acid and CTAB in the aqueous phase and particles with 
sizes up to 200 nm have also been created. [4] 
When nanoparticle synthesis uses a surface support, deposition-reduction 
or reduction-deposition, can be used. [1] Each process has two steps.  
The deposition-reduction method involves the deposition of AuIII 
compounds onto the support, followed by reduction into metallic gold 
nanoparticles under thermal treatment. [1] The reduction-deposition 
method utilizes gold precursors followed by reduction with stabilizing 
agents and deposition of the resultant gold colloids onto the support.  The 
deposition-reduction method is commonly used in the synthesis of small 
particles while the reduction-deposition method can synthesize different 
nanoparticle sizes depending on the different colloid preparations.   
The method used in this project for the creation of gold nanoparticles 
involved the use of a citrate reduction.  The citrate method can synthesize 
very stable gold nanoparticles with small sizes.    The chemical reaction to 
produce the nanoparticles is shown below:  
6Au3+ + C6H5O73- + 15OH- →	6Au + 6CO2 + 10H2O 
In the synthesis, trisodium citrate simultaneously acts as a reducing and 
stabilizing agent.  The monodispersity and size of nanoparticles can be 
controlled through the modification of reaction conditions.  For example, 
silver ions can adsorb to the surface of gold nanoparticles restricting the 
ultimate size of gold nanoparticles. [5] 
Once prepared, the surface of citrate-coated gold nanoparticles can be 
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modified for use in biomedical applications.  Citrate-capped spherical gold 
nanoparticles provide a negatively charged citrate surface, that can either 
bind to positive charges from proteins [6], react with cells via covalent 
conjugates [7], or functionalize with synthetic oligonucleotides [8]. 
b. Chemical and physical properties of gold nanoparticles 
Gold nanoparticles are classified into three types based on their size 
range: clusters containing sizes less than 2 nm, catalytic particles with 
sizes 2-10 nm, and plasmonic crystals with sizes from 10-300nm. [1] Gold 
nanoparticles with diameters from 1-10 nm are described using the 
‘monolayer protected cluster’(MPC) model, in which gold nanoparticles 
couple with three layers, central atoms which contain the inner gold atoms 
with a close-packed crystal structure, surface atoms which stay in outer 
layers as the surface, and surface protecting organic ligands or 
surfactants. [1,9] (Figure 4.1)  The surface atoms have more activity than 
the closed-packed atoms. [1]  
 
Figure 4.1. A structural model of a single gold nanoparticle. [1] 
Shape is also an important parameter. Gold nanospheres are formed at 
Surface protecting organic layer
Central gold atom layer
Packed in a fcc structure
Surface atom layer
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small sizes of 10 nm or less. As the size is increased, the particles can 
also take shape as nanoshells and gold nanorods. [10]  Nanoparticles can 
be charge stabilized or sterically stabilized.  Sterically stabilized gold 
nanoparticles are usually prepared with long-chain or dendritic polymers 
as the stabilizing agents. [11] These compounds produce steric 
stabilization in which polymers surround the surface of gold nanoparticles 
as layers. [9] (Figure 4.2) When the nanoparticles have zeta potentials 
from 20m V to -20 mV, insufficient electrostatic stabilization results in 
unstable nanoparticles; when the nanoparticles have sizes greater than 20 
mV or less than ~ 20 mV of zeta potential, the  particles have sufficient 
electrostatic repulsion in solution and they are stable. [9] 
 
Figure 4.2 Stabilization mechanisms of monolayer nanoparticles: A. 
electrostatic stabilization; B. Steric stabilization. [9] 
 
The zeta potential of nanoparticles can be affected by their environment or 
the presence of surface contaminants.  High salt environments produce 
aggregations that result from an overlap of double layers between gold 
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nanoparticles.   Alternatively, proteins and other biomolecules protect the 
surface charge of the gold nanoparticles making aggregation less likely. 
The chemical and physical properties of gold nanoparticles are dependent 
on their size and shape.  The optical reflectivity and the conductivity of the 
metals depends on the movement of quasi-free electrons in the ground 
state through the metallic crystaline structure.  When the nanoparticle size 
is smaller than 5 nm, the chemical/physical properties depend more on the 
surface effects than on internal characteristics.  When the nanoparticles 
narrow to 10 nm or lower, their melting points, surface areas and 
interatomic separation decrease, and the binding ability to other molecules 
increases.  Therefore, when nanoparticle sizes increase to 10-300 nm, the 
particles have a strong interaction with light as a result of the localized 
surface plasmon resonance (LSPR). [1,12]  
c. Optical properties of gold nanoparticles  
Gold nanoparticles have strong light absorption in the visible spectra 
because of the surface plasmon resonance (SPR) effect.[13]  The optical 
properties of gold nanoparticles are determined by the resonance 
wavelength, the extinction cross-section, and the ratio of scattering to 
absorption on the nanoparticle dimensions.[9]  Gold nanoparticles with a 
diameter smaller than 2 nm do not produce surface plasmon resonance 
because the plasmon bands almost completely quench in these 
nanoparticles.[9]  Gold nanoparticles of 2-100 nm exhibit surface plasmon 
resonance (SPR) as the dominating optical feature and these 
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nanoparticles tend to produce a bright red color in colloidal form.  When 
the gold nanoparticles increase the size, the wavelength of the maximum 
extinction shifts to longer wavelengths.  These red shifts are also 
associated with an increase in peak intensity. [14]  Gold nanoparticles  
larger than 2nm in size have an extinction cross-section with a light-to-
heat conversion at nearly 100% efficiency, high photostability, and the 
ability to amplify electromagnetic fields near the metal surface.  When gold 
particles are smaller than 60 nm, they have a balance between scattering 
and absorption.  The particles have multipolar effects when the particle 
size is bigger than 60nm. [1]  
Gold nanoshells have better optical cross-sections than nanospheres with 
the optical resonance occurring in the near-infrared region.   In general, 
increasing the size of gold nanospheres increases the resonance 
wavelength. [10]  Nanoshells also have a linear relationship between the 
size and their total extinction, and gold nanorods produce optical cross-
sections with a smaller effective size. [1,10] 
The size, polydispersity, and the shape of gold nanoparticles affects the 
SPR wavelength.  Particle aggregation also effects the SPR wavelength 
and other optical properties. [13]  For example, aggregation causes a red-
shift in the maximum absorption.  Color changes that result from particle 
aggregation have been used in many fields as a detection method. [1] The 
DNA-functionalized gold nanoparticles are widely used because of the 
color changes of red/blue of as the colorimetric indicator. [15,16] 
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d. Functionalized gold nanoparticles 
Gold nanoparticles can be modified through derivatization of the surface of 
the gold monolayer.  The addition of the surface functionalization involves 
an extra step in the synthesis of gold nanoparticles or through later mixing 
with other molecules. [1,9,17]  The common functionalization methods 
include PEGylation[18], peptide/amino acid conjugation[19], 
oligonucleotide functionalization[20], and others[21]. Gold nanoparticles 
can be easily modified depending on specific binding to thiol groups.  The 
physical and chemical properties of gold nanoparticles depend on the size 
of gold nanoparticles.  The modifications on gold nanoparticles change the 
surface charges and the size as well as the physical and chemical 
properties of the particles. [9]   
Overall, the method of synthesis, the size, and the surface charge affect 
the physical, chemical and optical properties of gold nanoparticles.  
Modifications to the surface change the properties of gold nanoparticles 
and increase their potential applications in biomedical fields.  Gold 
nanoparticles can produce a salt-induced aggregation and cause color 
changes from red to blue.  The salt based aggregation affects 
functionalized gold nanoparticles much less than pure gold nanoparticles, 
especially DNA-functionalized gold nanoparticles.  This salt-induced effect 
can be important in the bio-related applications in which a target is 
determined based on a colorimetric reaction. 
B. Aptamers 
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Aptamers are defined as small single-stranded DNA or RNA 
oligonucleotides which are able to bind target molecules with high 
specificity and affinity.[22]  They usually have sizes ranging from 20 to 60 
nucleotides, and they can bind different types of target samples which 
ranging from inorganic ions,  small molecules such as pharmaceutical 
compounds, large protein complexes and even entire cells. [22,23] 
Aptamers are considered nucleotide analogues of antibodies, but their 
preparation is much easier and less expensive. [24,25] The earliest 
method for the production of aptamers was described by Tuerk and Gold 
in 1990 who designed gp43 binding sequences. [26] Their procedure 
became to be known as Systematic Evolution of Ligands by Exponential 
Enrichment (SELEX). [27] A target molecule is used to select the most 
specific sequences from a combinatorial nucleic acid library of random 
oligonucleotides   These sequences are then PCR amplified and the 
process is until the most selective sequences are isolated. [27] The basic 
steps of the SELEX process are shown in Figure 4.3.  The beginning of a 
SELEX process utilizes a pool of chemically synthesized random DNA or 
RNA oligonucleotides with 1013 to 1015 sequence.  These sequences are 
incubated with the target.  In the next step a binding complex is separated 
from the unbound and weakly bound oligonucleotides.  The target bound 
oligonucleotides are removed and amplified by PCR (DNA SELEX) or 
reverse transcription-PCR (RNA SELEX).  The amplified sequences 
added to a new oligonucleotide pool and another cycle of SELEX is 
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initiated.  Several cycles of selection and amplification of the target 
oligonucleotides produces an increase in the affinity and specificity of the 
aptamer to the target.  The number of cycles depends on the size and 
number of binding sites on the target.  When matched oligonucleotides are 
cloned to create the aptamer clones, these aptamers are sequenced and 
analyzed to determine their binding properties.  Some aptamers may 
require extra modifications to meet special requirements such as 
heterogeneous surface binding. [27] 
 
Figure 4.3. In vitro selection of target-specific aptamers using SELEX 
technology. [27] A synthetic random DNA library containing ~105 
sequences is directly employed in the SELEX process for the selection of 
DNA aptamers.  Each cycle includes selection, amplification, and 
conditioning.  The target incubates in the library for binding, and the 
TargetNucleic	acid	library
Partitioning
Amplification
- PCR
- RT-PCR
Conditioning
Selected	
oligonucleotides	
library
1st	SELEX-round
Cloning
Designed	aptamers
SELEX	Process
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unbound sequences are washed out from the binding complex.  The 
target-bound oligonucleotides are then separated from the complex, 
copied and amplified by PCR.  The amplified oligonucleotides add to the 
next DNA library, and a new cycle for the target happens again.  Usually, 
an oligonucleotide with high affinity and specificity is prepared after 6-20 
cycles.  
 
Aptamers are a useful alternative to antibodies because their preparation 
is easier, more humane, and can be performed at a lower cost than 
antibodies. Over the past ten years, the development of aptamers has 
improved in terms of speed and selectivity.  Many of these molecules are 
applied as optical sensors through the incorporation of enzymes, 
nanoparticles, quantum dots (QDs) and dyes. [22]  
Aptamers have been successfully developed for the target molecules of 
inorganic ions [28], small organic molecules [29], nucleotides and 
derivatives [30], nucleic acids [31], peptides and proteins [27, 32]   With 
appropriate labeling or downstream processing, this binding step can be 
used to indicate the presence of the target molecule in an unknown 
sample. [ 33]  The detection of drugs and their metabolites  is a particularly 
important applications in the use of aptamers.  For example, a series of 
different aptamers have been developed to detect the presence of 
cocaine.  Since the target is a small molecule of 303.353 g/mol, specificity 
can be a difficult to achieve and the sequences utilized include ssDNA and 
RNA based aptamers.  The detection methods utilized for cocaine include 
fluorescence [34,35], electrochemistry [36,37] and colorimetric probes.  
Colorimetric methods can be separated into methods involving the 
  87 
monomeric dyes [38] and gold nanoparticles aggregation. [39,40] 
In summary, aptamers offer high selectivity and affinity to the target with 
easier preparation than current immunoassays.  These oligonucleotide 
 based biosensors can compete with other matrix elements to detect the 
target with minimal problems with interferences. 
C. Lateral flow immunoassay 
Many µPAD detection systems utilize the principle of lateral flow 
immunoassay (LFIA).  In LFIA, a liquid sample is deposited on the sample 
pad and moves through the pad via capillary action.  The analytes pass 
different zones where they are designed to interact with and/or bind to 
antibodies as well as gold nanoparticles.  A LFIA device consists of 
several parts: (1) sample application pad; (2) conjugate release pad; (3) 
membrane; (4) test line and control line; (5) wicking-absorbent pad. 
(Figure 4.4) A sample reacts with at least two lines located on the strips: a 
test line and a control line.  The test line captures and detects the complex 
of antibodies/analyte producing a color change resulting from nanoparticle 
aggregation while the control line detects unmodified analyte and/or 
indicates a proper flow of the liquid through the strip.  As the end of the 
strip there is an absorbent pad which absorbs the excess solvent.[24] 
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Figure 4.4 An example of a sandwich format of lateral flow immunoassay. 
[41] Samples are deposited on the sample pad and then move through 
capillary flow to the conjugated pad on membrane.  When the AuNPs/anti-
antigen 2 was captured by antibodies, it produced a red line in the 
antibody area.   
 
The LFIAs are divided into two types of assays, competitive and sandwich.  
The former detects analytes having a single epitope and low molecular 
mass while the latter detects analytes with larger molecular weight 
containing more than one epitope. [41]  The sandwich mechanism is more 
effective than the competitive assay.  The sandwich assay has a test line 
with one analyte-specific antibody, and a conjugate release pad containing 
a second, labeled, anti-analyte antibody.  The sample will bind during the 
primary process to the first antibody which is coupled to a gold 
nanoparticle.   Then the sample-antibody conjugate is detected at the test 
line through the interaction between the second epitope and can be 
immobilized antibody at the test threshold.  The response is directly 
proportional to the amount of analyte in the sample. 
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D. Gold nanoparticles/Aptamer based biosensors 
Aptamers couple with enzymes, nanoparticles, QDs and dyes as the 
biosensors.  Although QDs were first adapted to aptamer detection 
strategies by Levy and coworkers [42], gold nanoparticles become more 
increasingly popular because their absorption and optical properties 
change with the aggregation state.  The color changes associated with the 
aggregation (purple-blue) and disaggregation (red) are easily visible to the 
naked eye without sophisticated instruments.  In addition, gold 
nanoparticles are more biocompatible, easier to bio-conjugate, and less 
toxic than QDs. [1,9,34]  
Gold nanoparticles will aggregate in the presence of added salt.  However, 
gold nanoparticles can functionalize with biomolecules, and these 
functionalized nanoparticles can prevent the salt-induced aggregations 
from a low-salt solution even to an isotonic solution of salts. [43] 
Several groups have developed different aptamer/ gold nanoparticles 
based biosensors.  Most of published colorimetric methods utilizing 
AuNPs/aptamer based detection of cocaine are used in solution.  Li et al. 
[44] modified a AuNPs/apatmer complex using biotin.  In their device, 
biotinylated gold nanoparticle/aptamer complexes were added to a 
conjugation pad.  Next cocaine was added. Upon reaching the conjugation 
pad, the drug was trapped by the biotinylated AuNPs/ aptamer complex.  
The results in release of nanoparticles, which continue to flow downstream 
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response.  
In summary, gold nanoparticles can bind to aptamers with the result that 
these complexes can avoid salt-indicated aggregation. As a result, the 
DNA-functionalized gold nanoparticles maintain a red color in the 
presence of salt. In addition, the gold nanoparticles will aggregate together 
and produce a color change of blue in the presence of Mg salt solutions.  
Thus, functionalized nanoparticles can be used in colorimetric detection 
for target analytes.  
 
2. Goals  
The goal of the present project was to develop a paper-based microfluidic 
device to detect seized cocaine using specific drug binding aptamers and 
gold nanoparticles.  The project included the determination of the 
capability of gold nanoparticles to move and aggregate on paper chips as 
well as characterizing the mobility and binding capability of anti-cocaine 
aptamers.  In addition studies were performed on the potential 
modification of aptamers and gold nanoparticles for use in the detection of 
cocaine on paper microfluidic devices. 
 
 
 
 
 
where a streptativdin test line captures the nanoparticles producing a red 
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3. Chemicals and Methods 
I. Chemicals 
Gold (III) chloride trihydrate (≥ 99.9%) was purchased from Sigma-Aldrich 
(St Louis, MO).  Sucrose, magnesium chloride hexahydrate and sodium 
citrate dihydrate were purchased from Fisher Scientific (Fair Lawn, NJ).  
The DNA sequences described by Fan et al.[40] were used to create the 
aptamers ACA-1: ACAGCAGGGTGAAGTAACTTCTTG and ACA-2: 
GGGAGTCAAGAAC, and the sequences were purchased from IDT 
(Coralville, IA).  Cocaine standards were purchased from Sigma (St Louis, 
MO). 
II. Synthesis of AuNPs 
The preparation of AuNPs followed the reported produce. [45]  All 
glasswares washed with aqua regia and d.i. water as well as the air drying 
before the synthesis.  0.039 grams of tetrachloraurate (III) hydrate was 
dissolved in 100 mL of d.i. water to 1 mM and 11.41 grams of sodium 
citrate dehydrate was dissolved in 10 mL of d.i. water to 38.8 mM.  The 
solution of HAuCl4 was heated to the reflux under stirring, and then the 
citrate solutions added to the reflux solution for another 10 minutes.  After 
the addition of citrate, the pale yellow of the gold solution turned colorless 
and then black and finally wine-red in around 1 minute.  The molar ratio of 
Au: citrate kept 1:3.8 in the solution.  After 10 minutes, the flask with 
solutions sat in the ice bath for another 15 minutes.  The AuNPs solution 
transferred to the volumetric flask and kept the volume of 100 mL with d.i. 
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water.  The average particle size was determined by a dynamic light 
scattering measurement (ZetaSizer Nano, Malvern, UK ).   
III. Designs of µPADs  
Two single channel µPADs were designed to detect cocaine samples.  
(Figure 4.5).   The left design was used to detect the MDQ and the 
interference tests, and the right one was the design for the presumptive 
tests.  Both designs have 2 zones A and B.  Zone A was used to contain 
the AuNPs and the area was also used for colorimetric detection; zone B 
was the area used to deposit the aptamers.  A second design (left hand 
side) had a third region, zone C, which was used for the deposition of 
sample solutions.  A commercial wax printer (Xerox Color Cube 8750, 
Xerox, US) was used to print the single channel design on 
chromatography paper Whatman #1 (GE Healthcare, UK).  The paper was 
wrapped in aluminum foil and passed through a laminator at 160 °C, a 
speed of 1.6 cm/sec (Tamercia Tashin Industrial Corp, TCC-6000) for 5 
times.  The laminator is used to melt the wax into the paper and create 
hydrophobic barriers.  Samples and reagents are next deposited in the 
designed positions to optimize the color change on paper chips.  Figure 5 
showed the design of the device with letters indicating the potential 
locations of each reagent and samples.  A 2 μL of AuNPs dropped on 
Position A and 3 μL of ACA-1 and ACA-2 were separately added to 
Position B.  All reagents were added to μPADs and then dried.  Otherwise 
the solution sample would spread along its corresponding channel.  In the 
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detection tests, 1 μL of cocaine liquid samples were placed on Position C.  
In the reference tests, 1 μL of each sample was added to Position C. Vials 
were prepared for use with the carrier solution.  Each vial contained 300 
μL of 2.8M MgCl2/ 0.15mM sucrose (v:v=1:1).   
  
Figure 4.5. Left: The design of the AuNP/aptamer based μPAD used in 
these experiments.  Zone A: AuNPs area; Zone B: aptamer (ACAs) area; 
Zone C: Sample area.  Right:  A presumptive test was developed for 
cocaine detection using this device.   The process involves dipping a 
paper tab of the device into a solution containing the cocaine target.  The 
circled region (1) is the connecting channel between gold nanoparticle 
area and aptamer area. 
 
IV. Estimation of Visual LOD and MDQ 
A modified paper chip (Figure 4.5 Left) was used in the determination of 
LOD.  One μL of cocaine solution at a concentration from 1ng/mL to 
10mg/mL was deposited onto the sample area (zone C - Figure 4.5, 
Left).  Sample tests were repeated 9 times.  The visual LOD was based on 
the color intensity at which greater than 90% of a group were able to 
detect the difference between a positive sample and a blank. [47]  The 
camera-based LOD was performed using pictures recorded by a CCD 
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Camera from AmScope Inc. (Irvine, CA) attached to a Zeiss microscope 
(using a white background).  The microscope was set at a magnification of 
8x and a depth 1of 1.0 mm.  The digital camera was set to an exposure 
setting of 120, exposure time 509, and gain 1.20; Color temperature was 
6503 and Tint 1000.  Data analysis was performed by ImageJ software 
1.50i. The color analysis was performed in the AuNPs area. (zone A - 
Figure 4.5, Left) The camera based LOD was estimated as three times the 
standard deviation plus the blank signal (3s+b) of the quantity of drug at 
the inflection point for nanoparticle aggregation. 
V. Interference tests 
Publix granulated sugar, Arm & Hammer baking soda, ionized salt, Publix 
powdered sugar, King Arthur gluten free flour, Rumford aluminum-free 
baking powder, foot powder, tablets of Excedrin and ibuprofen, were 
purchased from supermarkets in Miami, FL.  Procaine was purchased 
from Acros Organics (Waltham, MA).  Caffeine, amphetamine, 
methamphetamine, ketamine, ephedrine were purchased from Sigma-
Aldrich (St Louis, MO).  Morphine and codeine were purchased from RBI 
(Natick, MA).  All samples were prepared as 1mg/mL solutions in water for 
tests.  Benzoylecgonine (1mg/mL) and ecognine methyl ester (0.1mg/mL) 
were purchased from Cerilliant (Round Rock, TX).   The modified device 
(Figure 4.5, Left) was used in the interference tests.  1uL of each 
interference solution was added to the sample area (zone C - Figure 4.5, 
Left) and each test was repeated three times.   
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4. Results and Discussion 
I. AuNPs/Aptamer detecting cocaine in solution tests 
Two sets of cocaine aptamers were tested in the solution tests. [39,40]  
Zhang et al. [40] developed a set of anti-Cocaine aptamers (ACA-1 and 
ACA-2).  This aptamer set included 2 unmodified DNA sequences, ACA-1 
with 24 bases and ACA-2 with 13 bases.  The mixture of ACAs and gold 
nanoparticles produced a color change from red to blue in the presence of 
cocaine and NaCl, but did not change with NaCl in the absence of 
cocaine.  Alternatively, Liu et al. [39] developed three sequences for 
cocaine detection.  According to their paper, the aggregated nanoparticles 
denature upon addition of cocaine and external heating, producing a color 
change from blue to red.  We examined this process and were able to 
successfully incubate the gold nanoparticles with the aptamers, but the 
decomposition of the aptamer/gold nanoparticles did not occur on 
efficiently.  Therefore, we reexamined the use of Zhang’s ACA aptamers.   
The advantage of this set of aptamers was their sensitive to the presence 
of cocaine (as low as 2 μM [40]) and their quick reaction in solution tests.  
In addition, these aptamers were unmodified and less expensive to 
produce than those requiring biotin or thiol functional groups.  The 
detection mechanism for the paper device was based on the capability of 
the free aptamers to bind cocaine or the surface of the gold nanoparticles.  
This binding process was thermodynamically favored and did not require 
external energy.  In comparison, the aptamers created by Liu et al. [39], 
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could not be used in homogeneous assays as they required heating to 
separate the aptamers from the gold nanoparticles prior to binding 
cocaine, making the tests difficult to operate.  
Picture 4.6 shows the production of color changes involving the change 
from a red-wine color to the purple color in the presence of cocaine.  
 
Figure 4.6. AuNPs/Aptamer based solution test for cocaine samples.  In 
the absence of cocaine, the two ACA aptamers bind to the surface of gold 
nanoparticles and the complex does not aggregate with NaCl.  The 
resultant mixture produces a red color.  In the presence of cocaine, ACA 
aptamers bind to cocaine molecules and the gold nanoparticles aggregate 
producing a purple color.  Left: Blank sample test; Right: cocaine sample 
test.  
 
 II. AuNPs on μPADs 
The original μPADs design for cocaine detection was determined by 
changes in mobility causing aggregation of AuNPs on paper chips.  Other 
applications of AuNPs on μPADs only used μPADs as a platform for 
detection [48,49], however, we have designed our system as a ready-to-
use detector. The system permits sample analysis and detection based on 
capillary flow along a hydrophilic channel to the designed position where 
salt-induced self-aggregation and color development occurs.   
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a) Preparation of AuNPs on μPADs 
A number of procedures were used in preparing the μPADs for analysis.  
These included immersion and deposition procedures.  In the immersion 
method, the entire chromatographic paper was placed in a AuNP solution 
in which concentrations ranged from 1 mM to 0 mM for times ranging from 
1 to 24 hours.  When the immersion period was less than 12 hours, the 
AuNPs did not attach to the paper and the color of paper was pale pink to 
colorless.  When the time was increased to 24 hours, the AuNPs appeared 
on chromatographic paper as a red color.  The intensity of the color varied 
with concentration.  Nanoparticles at a concentration from 0.5 mM to 0.6 
mM, appeared dark red.  Unfortunately, when AuNPs at concentrations of 
0.5 mM or higher were used the color changed to purple-red or black 
when the paper dried, while AuNPs of 0.4 mM or lower appeared colorless 
on paper.  Therefore, the immersion method can be used in the 
aggregation of AuNPs on paper for other purposes, but it was not 
appropriate for use the colorimetric detection. 
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Picture 4.7. Effects of different concentration of AuNPs on 
chromatographic paper based on an immersion method.  Gold 
nanoparticles were stable at concentrations below 0.6 mM in immersion 
methods on paper chips. 
 
An alternate method for application to the paper was the deposition 
method.  A zone was created on the paper with an inner diameter of 
3.5mm (Figure 4.5) and 2 µL of a solution containing 1 mM, 0.5 mM, and 
0.25 mM of AuNPs were tested in this area.  The resulting color produced 
on the paper was a pink-red color with the 1mM solution while the 0.5 mM 
and 0.25 mM solutions produced a paler color which was hard to see.  
Therefore, 1 mM was the preferred concentration for the colorimetric 
detector. 
When the synthesized AuNPs contained ~15% AuNPs of 15nm, the 
deposition of AuNPs appeared as red color on the AuNPs area but also 
produced a darker red or purple-red in the connecting areas.  Depending 
on the distance between the point of application and the paper, sometimes 
the red color was darker in the external areas when compared to the 
middle of the deposition area.  It was assumed that the darker spots on 
0 mM
1 mM
0.6 mM
0.7 mM
0.8 mM
0.9 mM
Wet Dried
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the paper were due to the aggregation of the larger sizes of AuNPs. 
To examine the effect of different quantities of AuNPs on paper, different 
volumes of 1mM AuNPs (2 µL, 4 µL, 6 µL, 2 µL *2 times, 2 µL*3 times) 
were added to the same position.  When the volume of a single drop was 
higher than 2 µL, the AuNPs spread to the connecting channels and this 
region turned black.  When multiple applications of small quantities of 
nanoparticles were added, the spreading effects decreased but the 
aggregation of the AuNPs in the designed positon increased and the area 
turned to purple-black.  Therefore, a single deposition of 2 µL AuNPs of 1 
mM was defined as the best method to optimize color effects on 
chromatographic paper. 
 
b.  Mobility of AuNPs on µPADs 
In the original design, the AuNPs were expected to move to the end of the 
channel with the capillary flow.  Unfortunately, the AuNPs did not move 
with the either water or sucrose on unmodified chromatographic paper.  
The AuNPs also aggregated on the micropads containing sucrose and 
water without any salt. (Figure 4.8) 
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Figure 4.8. Effects of AuNPs paper without PVA/Tween 20 Treatments. 
 
Therefore, it was necessary to perform surface modifications to the paper 
devices in order to increase the mobility and decrease the aggregation of 
AuNPs.  Previous results using lateral flow devices [39] have indicated 
that AuNPs can move through membranes following the addition of 
sucrose.  Surfactants such as Tween 20 and Tween 80, as well as the 
polymer poly(vinyl alcohol) (PVA) were also added to the paper to 
examine their effect on the mobility and aggregation of the nanoparticles.  
The modified paper was then immersed in the gold nanoparticles solutions 
for 24 hours.  Tween 80 did not decrease the aggregation of AuNPs which 
turned to purple; Tween 20 decreased but did not eliminate the 
aggregation of AuNPs which turned to darker red while PVA minimized the 
aggregations yielding a pink-red color.  Solutions of PVA from 0.01% to 
1% provided the same color effects.  However, AuNPs on PVA treated 
paper were too stable, these AuNPs did not move with capillary flow with 
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using sucrose solutions or distilled water.   
To optimize the mobility and the stability of AuNPs on treated paper, we 
next examined mixtures of 0.01% PVA and 1% Tween 20 with different 
ratios (1:1, 1:9, 1:99).  All treatments stabilized the AuNPs on paper, 
producing a red color.  As the quantity of AuNPs on the paper increased, 
the darkness of the red color increased.  To optimize the movement of the 
AuNPs, we examined different quantities of AuNPs at different ratios of 
PVA/Tween 20 and sucrose. The spotting positions are illustrated in 
Figure 4.9-top.  With 0.15mM sucrose, the only successful condition was 
1% Tween20/ 0.01% PVA (v:v=99:1) spotted in location 1 with AuNPs.   
As shown in Figure 4.9-a, we could observe color 
 
Table 4.1.  Effects of surfactant/ polymers modified AuNPs paper.  PVA 
inhibited the aggregation of gold nanoparticles on paper, Tween 20 
inhibited most of the aggregations of nanoparticles, Tween 80 does not 
inhibit nanoparticle aggregation.   
 
 
AuNPs/ PVA AuNPs/ Tween 20 AuNPs/ Tween 80
Wet -> Dried No Aggregation SomeAggregation
Some 
Aggregation
Phenomena 
Deposited Water No Aggregation No Aggregation Aggregation
Deposited 
5M NaCl No Aggregation
Some 
Aggregation Aggregation
Deposited 0.15mM 
Sucrose/5M NaCl No Aggregation
Some
Aggregation Aggregation
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movements from position 1 (lower ball) to position 2 (top ball) with a 
solution containing 40mg/mL of sucrose, 50%Tween 20, and 1%PVA.   
More AuNPs moved to the end of the channel when the paper chips were 
treated with 50-30% Tween 20 mixed 1-0.1% PVA. (Figure 4.9-b)  To 
optimize the movement of AuNPs, we tried different ratios of AuNPs to the 
PVA/Tween 20 along with 50 mg/mL sucrose.  When the ratio of AuNPs: 
PVA/Tween 20 (v:v) was above 4:1, the moving distance and the darkness 
of the red color were obvious to the naked eye. (Figure 4.9) The whole 
procedure took around 10 minutes. 
 
Figure 4.9. Effects of surface treatments on paper for AuNPs.  Bottom: 
Left: AuNPs paper before test; Right: (a) 50mg/mL sucrose with the 1% 
Tween 20: 0.01% PVA in location 1; and (b): 40mg/mL sucrose with the 
50% Tween 20: 0.01% PVA in location 1. 
 
!
!
!!!!!!!!!!!!!!!!!!!!!!!!!!Left!!!!!!!!!!!!!!!Right!!!!(a)!!!!!!!!!!!!!!!(b)!!!!!!!!!!!!!!(c)!
!
PVA/Tween 20
Sucrose
AuNPs1
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There were several problems when examining the mobility of the AuNPs 
on µPADs.  The biggest issue was the low reproducibility of the moving 
AuNPs.  We controlled all conditions in the preparations and operations, 
however, the same batch of AuNPs often produced different results.  A 
larger quantity of AuNPs on the paper was required to achieve movement 
of AuNPs, but this process produced colors from red to purple in the 
designed position.  If the width of the moving channel was reduced, the 
time increased to 1 hour and most AuNPs aggregated in the middle of the 
channel. If the moving channel was wider, the AuNPs moved past the wax 
barrier.  Therefore, the design of this µPAD had to be changed.   
c. Aggregations of AuNPs on µPADs 
In earlier work, we found that a single deposition of 2 µL AuNPs of 1 mM 
produced a red color on chromatographic paper.  Also as noted, AuNPs 
aggregate in solutions with the presence of salts. [1]  Thus further testing 
was performed on the ability of different  concentrations of AuNPs to 
produce aggregation. Table 4.2 shows that a concentration of 1 mM can 
produce complete aggregation in the presence of salts and sugars.  
Decreasing the concentration of gold nanoparticles reduced the 
aggregation effects.  Sodium chloride and magnesium chloride were 
examined in both solution and on µPADs to examine their effect on 
aggregation.  Magnesium chloride produced a more intense color of 
AuNPs aggregation in both tests.  Therefore, magnesium chloride was 
used as the aggregating agent in the moving solution.  Sucrose did not 
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cause aggregation in solution, however, gold nanoparticles did aggregate 
on the µPADs as a result of the capillary flow of sucrose into their zone.   
After tests of the mobility and aggregation, we utilized the aggregation of 
AuNPs on µPADs instead of their mobility on µPADs as the colorimetric 
detector.  The next step was to determine if aptamers could bind AuNPs 
on µPADs. 
 
Table 4.2.  Aggregation effects of AuNPs on µPADs.  The color in the 
table indicated the color change happened on µPADs.  Black = Full 
aggregations, Purple = Partly aggregations, Brown-red = little 
aggregations, Red = No aggregations. 
 
 
 
 
! Type! AuNPs!#1! AuNPs!#2! AuNPs!#3!
AuNPs!concentrations! 1mM! 0.5mM! 0.25mM!
w/out!
Surface!
treatment!
Sucrose! ! ! !
MgCl2! ! ! !
NaCl! ! ! !
Sucrose!+!
MgCl2!
! ! !
Sucrose!+!
NaCl!
! ! !
!
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III. Aptamers on μPADs 
In our design, aptamers have two functions, (1) binding to gold 
nanoparticles to avoid aggregation in the presence of salts; (2) binding to 
cocaine.  Gold aptamers should have sufficient mobility in the carrier 
solutions to permit moving through the channel via capillary action, and 
the ability to bind to the cocaine molecules.   
Aptamers are colorless in solution so we needed a visual detection 
procedure for µPADs tests.  To do this we used SYBR Gold and SYBR 
Green fluorescent DNA labeling dyes to track the presence 
and movements of aptamers on paper chips.  2uL of dye and the ACAs 
aptamer were separately dropped to the bottom-ball position on paper 
chips. (Figure 4.10) Sucrose can move the aptamers through the 
membrane, and the higher concentrations of sucrose can move even more 
aptamers on a solid matrix. [39] A series of sucrose with different 
concentrations were examined.  0.15mM of sucrose moved aptamers with 
a highest speed.  When the paper dried, these paper chips were put in 
50mg/mL of sucrose solution until the moving solution arrived at the end of 
the channel.  A molecular imaging software of KODAK MI and a Gel Logic 
100 were used to record the fluorescence of aptamers on paper chips.  
The detected fluorescence indicated the positions of the aptamers after 
the tests.  Figure 4.10 showed that the dyes stayed in the bottom ball in 
the blank test, but the dyes moved up to the end of the channel in the 
presence of the aptamers.  The moving fluorescence position 
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demonstrated that the aptamers can move through the channel on µPADs 
with sucrose.  There was fluorescence in the middle of channel, indicating 
that the optimized conditions for the mobility of the aptamer should be 
either include a longer time for capillary action, or a shorter channel to 
transform more aptamers.  
 
 
Figure 4.10. Movements of Dyes and Dye/Aptamer on paper chips with 
50mg/mL of sucrose. Left: SYBR Gold only; Mid-left: SYBR Gold-ACA-1; 
Mid-right: SYBR+ACA-2; Right: SYBR Gold ACA1&ACA2. 
 
The paper chips were next used to observe the binding of the ACAs 
aptamers with cocaine in Figure 4.11.  SYBR Green 5x was used as the 
tracking dye.  4 uLof SYBR Green mixed ACA-1 and ACA-2 was 
deposited at the bottom ball.  1mg of Cocaine was dissolved in 40mg/mL 
sucrose.  The bottom of the paper chip was placed in the sucrose solution 
for 10 minutes and the fluorescent response was photographed in each 
the channels as shown in Figure 4.6.  The single aptamers or cocaine did 
not produce fluorescence with SYBR Green.  The application of a mixture 
(a)$$$$$$ (b)$$$$$$ (c)$$ (d)
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of the two ACAs produced a fluorescence signal and the mixture of 
ACAs/cocaine enhanced the intensity of the fluorescence.  ImageJ 
software was used to analyze the optical density of the top channels from 
Figure 4.11, and the average optical density of ACA mixture/SYBR Green 
was 0.005367, and the average optical density of ACA/SYBR Green/ 
Cocaine was 0.005521.  The intensities indicated that ACAs can move 
through the channel of µPADs and they can also bind cocaine on µPADs. 
 
  
Figure 4.11: Results of SYBR Green with cocaine, ACAs and their 
mixtures.   
1. Only SYBR Green 5X;  
2. SYBR Green 5X + Cocaine, 1mmol    
3. SYBR Green 5X + ACA-1, 1mmol;  
4. SYBR Green 5X + ACA-1, 1mmol + Cocaine, 1mmol;  
5. SYBR Green 5X + ACA-2, 1mmol;  
6. SYBR Green 5X + ACA-2, 1mmol + Cocaine, 1mmol;  
7. SYBR Green 5X + ACA-mixture, 0.5mmol of each ACA; ACA 
mixture/SYBR Green produced a fluorescence.  
8. SYBR Green 5X + ACA-mixture, 0.5mmol of each ACA + Cocaine, 
1mmol.  ACAs/ SYBR Green/ Cocaine produced a brighter fluorescence in 
the end of channel. 
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IV. Aptamers/AuNPs complex on µPADs 
a) Designs  
The next step was to modify the aptamer/AuNPs assay to permit the 
usage in μPADs as demonstrated in Scheme 1 (Figure 4.12).  A series of 
experiments were performed examining the stability and mobility of the 
various components of the detection scheme.  Initial tests indicated that 
the gold nanoparticles bound strongly to the paper matrix. Thus, these 
were placed at the end of the channel.  Aptamers were placed in a zone 
upstream of the AuNPs area.  When the samples moved with the carrier 
solution, the ACAs bind to the targets and then the complex of 
aptamers/cocaine move toward the AuNPs area.  Without the protection of 
the free aptamers, the AuNPs would aggregate under due to salt-induced 
aggregation.  When the sample was not cocaine, the ACAs move with 
carrier solution and bind to the surface of the AuNPs eliminating the 
possibility of aggregation.   
A series of experiments were next performed to test the stability and 
mobility of the various components of the detection scheme.  The results 
were shown in Table 4.3.  In the absence of aptamers, AuNPs on the 
μPADs produced a color change with the capillary flow of water, sucrose 
or sucrose/MgCl2.  In the presence of aptamers, the red color of AuNPs 
changed to purple when water was introduced.  When the aqueous 
solution included sucrose, the red color turned to a darker red.  With an 
aqueous solution containing sucrose and MgCl2, the color changed to red-
  109 
purple. The next step was to optimize the concentration of the solution to 
produce an intense color change.   
b) Moving solutions 
The components of carrier solutions were important, as these contain the 
salt which produces the aggregation of AuNPs, and the sucrose which 
assists the movement of the AuNPs, and increases the binding of 
aptamers to AuNPs surfaces.  A range of concentrations of salt and 
sucrose were examined.  The best results occurred with a MgCl2 
concentration of 2.8m and 50mg/mL sucrose.  Higher concentrations of 
sucrose reduced capillary flow while lower amounts of MgCl2 did not 
produce full aggregation. These results suggested that the sucrose in the 
system helped to mobilize the aptamers towards the end of the channel 
[39], and that the MgCl2 acted as the aggregating agent of the AuNPs.  
The optimized sucrose/MgCl2 resulted in a salt-induced aggregation in the 
presence of cocaine.  The aggregation was inhibited in the absence of 
cocaine, Table 4.3. 
Table 4.3.  The effect of different reagents on the aggregation of gold 
nanoparticles on the paper microfluidic device. 
 
AuNPs Aptamers Moving S. Cocaine Color Result Detection 
2 nmol n/a Sucrose/ MgCl2
n/a Black -
2 nmol 6 nmol Sucrose/ MgCl2
n/a Red Negative
2 nmol 6 nmol Sucrose/ MgCl2
Crack 
Cocaine Black Positive
2 nmol 6 nmol Sucrose/ MgCl2
Cocaine 
HCl Black Positive
!
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Figure 4.12. Schem
atic of the detection 
of cocaine using AuN
Ps w
ith aptam
ers.   
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c) AuNPs/Aptamers on μPADs 
The visibility of the color change on the μPADs depended on the quantity of 
AuNPs and the method of addition.  Lower concentrations of nanoparticles were 
difficult to detect once the colloidal gold solution dried on the paper.  2uL of 1 mM 
AuNPs deposited on the paper device with a size ranging 20 - 40nm produced a 
pink-red color on the μPADs visible to the naked eyes.  The color changes that 
occured when AuNPs were used on μPADs in the absence of cocaine depended 
on the quantity of the two aptamers on the paper.  AuNPs are sensitive to salts 
and produce salt-induced aggregation with the carrier solution of MgCl2 if 
aptamers are not present.  When present, the aptamers flow down the chip with 
the capillary flow of the MgCl2/sucrose solution.  When the aptamers arrive at the 
AuNPs area, they inhibit aggregation even in the presence of the salt solution.  
Figure 4.13 demonstrates that a linear relationship exists between the quantity of 
the two aptamers and the red colored response on the paper (red component of 
the RGB.) When the total amount of the two aptamers was less than 1.2 nmol, 
the deposited AuNPs turned to gray indicating that the quantity of the two 
aptamers was insufficient to bind to the surface of AuNPs and avoid aggregation.  
When the aptamer quantity was 1.2 nmol or more, the aggregation of AuNPs 
decreased and the color changed only from purple-red to light purple. At 8 nmol 
or higher, AuNPs area remained red, indicating that a sufficient quantity of 
aptamer was present to bind to the 2nmol AuNPs.  This was judged to be the 
optimal amount of aptamer. (Figure 4.13) 
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At higher concentrations, a loss of sensitivity occurred.  The binding effects 
between AuNPs and aptamers for solution tests required a 1:1 molar ratio.  On 
paper however, a larger amount of aptamer was required to avoid the salt-
induced aggregation.  The color change of purple-red was hard to observe.  The 
expected color was purple-black or black as an indicator for the presence of 
cocaine.  The optimized amount was 1.2 nmol of ACAs which achieved the best 
sensitivity.     
 
Figure 4.13.   The effect of increasing quantities of the two aptamers applied to 2 
nmol of the AuNPs on paper.  As the concentration increases a red color 
appears.  The optimum amount was 1.2 nmol of the aptamer mixture as this 
amount achieves the best sensitivity.  
 
Figure 4.14. The color change produced when the sucrose/MgCl2 solvent front 
mixes with 2nmol AuNPs in the presence of differing amount of Aptamers on the 
μPAD. A linear response is obtained as y=-0.004 – 0.01x, R2=-0.98.  Error bars 
represent standard deviations of triplicate measurements.[46] 
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b) AuNPs/Aptamer based uPADs detecting cocaine 
In these experiments a range of different designs were applied in the detection of 
cocaine.  The channel design (length and width) affects run time and can affect 
the binding of cocaine/ACAs and the aggregation of AuNPs with salt.  In the 
current design (Figure 4.5), the dimensions are 4mm (length) * 2mm (width) in 
the circled positions. These dimensions permit the carrier solution to move the 
samples through the chip within 5 minutes, and provide a visual LOD of 2.5 μg 
and an instrumental LOD of 2.4 µg.  However, if this area is increased to 6mm (L) 
* 1mm (W), the visual LOD drops, however, the run time increases to 30 minutes 
or more 
 
 
Figure 4.15. Example of the application of the μPAD in the detection of cocaine 
HCl.  Left: 5mg/mL cocaine sample.  Right: Blank sample. 
 
In a typical experimental test, AuNPs (2nmol) and aptamers (ACA-1 and ACA-2, 
0.6nmol each) were prepared and added to the μPADs.  In the presence of 10μg 
cocaine, a solution of 2.8M MgCl2/ 50mg/mL sucrose moved through the aptamer 
zone to the next location containing the AuNPs.  Once this solution reached this 
region, the AuNPs turned from pink-red to gray in 5 minutes.  In contrast, in the 
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absence of cocaine, the moving solution arrived at the end of the channel, and 
the AuNPs area remained red. (Figure 4.15) All color changes were apparent to 
the naked eye.  The color changes of AuNPs indicated that aptamers could form 
a tertiary structure around the cocaine not only in the solution but also on the 
μPADs. Furthermore, AuNPs can produce a salt-induced aggregation on μPADs 
and aptamers can stabilize AuNPs against the aggregation on μPADs. (Figure 
4.13) Experiments were next performed to define the optimized conditions for 
stabilization of the AuNPs and Aptamers on μPADs, while still permitting a 
sensitive and robust method to detect the presence of cocaine.   
 
c) Estimation of visual LOD and MDQ 
Figure 4.15 illustrates that the relationship between the response of the red 
component and the quantity of cocaine detected.  When the cocaine amount was 
0.1μg or lower, the AuNPs had a red/red-purple color. At amounts of cocaine of 
0.5μg or higher a purple color change occurred and at 2.5μg or higher, the color 
became grey-purple.  The visual LOD was based on the color intensity at which 
greater than 90% of a group of 13 individuals was able to detect the difference 
between a positive sample and a blank.  The camera-based LOD was calculated 
at the inflection point for plot of red absorbance vs cocaine concentration.  As is 
illustrated by the figure, at 1.7+/- 0.2 ug of cocaine a rapid transition occurs due 
the cocaine induced aggregation of the nanoparticles.  This point was used to 
determine a camera-based LOD of 2.36 µg (3s+b).  The LOD was consistent 
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over a range of 0.6 to 3.6nmol of each aptamer and 2 to 4 nmol AuNPs on the 
μPADs.   
 
 
Figure 4.16.  The effect of increasing quantity of cocaine on  the response  of red 
component (RGB) from image J.  As seen in the figure, at a signal intensity of 
139, an inflection point occurs.   This point is used to estimate the camera based 
LOD of 2.36.   The standard deviation of the estimate at the inflection point was 
0.20 ug. The visual LOD was estimated based on a signal sufficient for 90% of 
subjects to detect the color change and was 2.5 ug of cocaine.  
 
Table 4.4. Estimation of instrumental LOD and visual LOD. 
Drug Instrumental LOD Visual LOD 
Cocaine 2.36 μg 2.5μg 
 
b) Interference tests 
Common white powders including baking soda, salt, powder sugar, flour, baking 
powder, foot powder, Excedrin and ibuprofen were tested as potential 
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interferences.  All tested interferences maintained an intense red color indicating 
a negative result.  Common diluents used in illicit samples,  
 
Table 4.5. Interference tests.  All listed interference materials produced negative 
results of red colors 
 
 
such as sugar, procaine, caffeine and inositol also produced a negative result. 
Illicit drugs such as ephedrine, codeine, ketamine, amphetamine, morphine, and 
Interference 
Compounds Types Amount (ug) Results
Benzoylecgonine Metabolite 1.5 No Aggregation
Ecgonine methyl 
ester Metabolite 0.15 No Aggregation
Ketamine Drug 1.5 No Aggregation
Codeine Drug 1.5 No Aggregation
Morphine Drug 1.5 No Aggregation
Ephedrine Drug 1.5 No Aggregation
Amphetamine Drug 1.5 No Aggregation
Methamphetamine Drug 1.5 No Aggregation
JWH-073 Drug 1.5 No Aggregation
Caffeine Adulterant 1.5 No Aggregation
Procaine HCl Adulterant 1.5 No Aggregation
Sugar Diluent 1.5 No Aggregation
Sucrose Diluent 1.5 No Aggregation
Inositol Diluent 1.5 No Aggregation
Excedrine Common powder 1.5 No Aggregation
Ibuprofen Common powder 1.5 No Aggregation
Foot powder Common powder 1.5 No Aggregation
Baking soda Common powder 1.5 No Aggregation
Sea Salts Common powder 1.5 No Aggregation
Flour Common powder 1.5 No Aggregation
Powder sugar Common powder 1.5 No Aggregation
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JWH-073 did not produce a color change; methamphetamine produced a 
reddish-purple color. Metabolites of cocaine, benzoylecgonine and ecgonine 
methyl ester were also negative. (Table 4.5)   
 
5. Conclusions  
A rapid and specific method using an AuNPs/aptamer based paper microfluidic 
device has been developed for the field tests of seized cocaine.  The stamp-size 
paper device produces a detectable color change by the naked-eye or camera. 
The method can detect microgram levels of cocaine in under 5 minutes.  The 
procedure uses environmentally friendly reagents in a flexible format.  Compared 
to current colorimetric testing procedures, the newly developed μPADs are 
inexpensive and easy to use.  When tested against a wide variety of potential 
interferences, the μPAD has shown a high specificity and sensitivity.   
Furthermore, this strategy has the potential to detect other illicit drugs as new 
aptamers are developed.   Overall, we believe this general procedure can benefit 
the forensic detection of many types of illicit drugs. 
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Chapter 5. Conclusions and Future Work 
1. Conclusions 
In forensic analysis, presumptive tests for drugs of abuse may be performed on-
site or in a laboratory setting.  With increasing laboratory backlogs, on-site and 
point-of-care based testing have become important ways to prescreen samples 
as well as to provide probable cause that a crime has taken place.  The 
colorimetric response from this type of presumptive test depends on the 
sensitivity of the test and the sample type. Colorimetric tests are typically used 
for seized drugs, while antibody-based, lateral flow immunoassay techniques are 
used for trace detection of drugs in toxicological samples such as saliva, sweat 
and urine.  Although these methods are cheap and easy to use, they generally 
lack multiplex capabilities, thus several individual tests are required to determine 
the range of potential analytes.  Since these procedures are presumptive, false 
positive results can occur due to lack of specificity, and false negative results can 
occur due to environmental interferences. 
This project was designed to improve the specificity and sensitivity of screening 
tests through the development of paper-based microfluidic devices for drug 
detection.  These tests will be cheap, simple to use, and will provide rapid 
response times.  Two different paper-based devices have been developed.  The 
first device was based on adapting current colorimetric tests to a paper based 
format.  Analytes included classes of seized drug samples such as opiates, 
phenethyl amines, amphetamines and cocaines.  The second type of device was 
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designed to utilize gold-nanoparticle coupled reagents. 
The construction of the paper-based microfluidic devices was relatively simple 
and only required chromatographic paper, wax-ink and a laminator.  Wax ink 
provides a hydrophobic barrier and the paper substrate creates hydrophilic 
channels.  This device utilizes capillary action to move the solvents, reagents and 
drugs to the designed position, where previously deposited sample reagents 
produce a color change, indicating a positive result.  An advantage of the paper 
based approach is that multiple channels can be designed to simultaneously 
detect the presence of different analytes in a mixture.  
 
(1) Colorimetric reagents based uPADs 
Standard colorimetric reagents used in drug testing were modified for use with 
paper chips.    These reagents are generally based on the detection of certain 
functional groups and commonly involve interaction with transition metals.  We 
have developed a modified set of colorimetric reagents for the presumptive 
detection of seized drugs to permit their use with paper microfluidic devices. 
Reagents are placed in series along the length of each channel to permit 
reactions to occur at set locations and times.  The result is a safe and easy to 
store device that permits detection of a wide variety of controlled substances and 
just slightly bigger than the size of a postage stamp. The multiplex test can be 
read in under 5 minutes and is stable for up to 3 months.  The paper microfluidic 
tests are inexpensive and simple to operate. 
 
developed for on-site detection of cocaine with aptamer based lateral flow assays 
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(2) Gold nanoparticles/aptamers 
Aptamers are alternatives to the lateral flow immunoassays that are currently 
used.  Aptamers have the capability to bind specific target molecules, they have 
high selectivity and affinity.  The change between dispersion and aggregation of 
gold nanoparticles produces a color change from red to blue. The color appears 
when hybridized DNA coupled nanoparticles are released from the aptamers, 
following the binding of the aptamer to a target drug.   A rapid and specific 
method using a AuNPs/aptamers within a paper microfludic device has been 
developed for the field testing of seized cocaine. The stamp-size paper device 
produces a detectable color change by the naked eye or camera and can detect 
microgram levels of cocaine in under 5 minutes. The procedure was found to be 
selective against a wide variety of potential interferences. Furthermore, this 
strategy has the potential to detect other illicit drugs as new aptamers are being 
developed.  
2. Future Work 
The current work provides proof of concept for paper microfluidic devices as 
useful platforms for seized drug determination.  Prior to implementation, a more 
extensive the validation of the current paper microfluidic devices would be 
necessary before implementation in laboratory operations.  This would include 
testing of a wide range of drug substances and interferences.  In addition, round 
robin tests of reproducibility and sensitivity as well as determinations of false 
positive/false negative rates should be undertaken. The effect of variations in 
  126 
reagent concentration and accuracy should also be performed.   It is important to 
note that for the multichannel device, most of the reactions have previously been 
well characterized in terms of sensitivity and specificity for many years. [1,2] 
Aptamer tests are relatively new, but there is a great body of literature on their 
application. [3] 
Future studies for drug analysis may also involve new color tests and channels 
for other dangerous drugs such as cathiones and cannabinoids can be 
developed.  Lastly, aptamers designed for the determination methamphetamine 
and codeine have been published.  Initial laboratory studies have demonstrated 
that the approach used for the determination of cocaine will also work in 
methamphetamine and codeine determination. Thus this general procedure 
should prove useful for a wide range of analytes so long as similar aptamer 
based binding mechanisms can be developed.  
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APPENDIX I 
Table 4.5 The original records of the interferences tests. 
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APPENDIX II 
Calculation of the cost of paper microfluidic devices in this project. 
a. AuNPs/Aptamers based paper chips 
For each chip: 10 cents 
- Aptamer = $ 0.07548 (ACA-1, $22.10/umole, $40.80/umole) 
               $ 62.9/umole * 1.2 nmole = $ 0.07548 
              Total $ 0.07548/chip 
- AuNPs  
              HAuCl4, $56.982/g * 0.039g/100mL * 2uL = $ 0.00004445 
              Sodium citrate, $ 0.039/g*11.41g/100mLl*2Ul = $ 0.0000088 
              Total $ 0.000053/chip 
- Chromatographic Paper & Wax ink = $ 0.00923 (1cm * 2cm) 
              $ 0.6595/ A4 size chromatographic paper, each A4 size paper can 
prepare 72 chips, each chip = $ 0.00915 
              Xerox, ColorQube 8570 Black solid ink, $154.99/ 4 packs,  
              each pack $38.7475, each ink pack yields approximately 8600 pages 
from their website data,we assume each pack prints 8000 pages, each page cost 
$ 0.00484, each page prepare 72 chips, each chip will cost $0.000067 for ink 
              Total $ 0.0092 
- MgCl2 = $ 0.0025 
              $0.1822/ gram * 5.6M * 150 µL = $ 0.00250 
- Sucrose = $ 0.0005 
              $ 0.03122/ gram * 100mg/mL * 150µL = $ 0.0004683    
Above all, the total cost is = $ 0.0877 
 
b. Colorimetric reagent based paper chips 
For each chip: 10 cents  
Chromatographic Paper & Wax ink = $ 0.00923 (1cm * 2cm) 
All chemicals using in the test costs less 10 cents.    
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* Cut-off concentration * 50 uL  
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